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Editors’ Foreword
The International Undergraduate Journal of Health Science (IUJHS) serves as a
platform for undergraduate degree students to have their research, peer-reviewed, edited, and
published. Getting published as an undergraduate student is a rare and perhaps intimidating
prospect. The aim of IUJHS is to make publication more accessible to thousands of
undergraduate students across all disciplines of health science. While the inaugural and this
second issue contain submissions from the MTU/UCC BSc (Hons) Biomedical Science
students and the associated MTU Diploma in Clinical Laboratory Practice colleagues only, we
hope to present the first of our international articles in our next issue. We hope that its content
will further undergraduate health science education in addition to providing the usual benefits
of peer-reviewed research reporting in any scientific journal.
IUJHS is a twice-yearly modern, student-run, and peer-reviewed journal. In keeping
with the student-centered objective of this journal, the editorial board comprises of chief
editors; Shane Cusack and Ruth Delahunty, assistant editors Katie O’Brien, Evelyn Hayes, and
Clíodhna Ní Shúilleabháin and a panel of student reviewers (see a full list of editorial board
members), all of whom are undergraduate students. The current editorial board looks forward
to the prospects of the journal and the opportunities it will present to undergraduate students
studying health science in Ireland and further afield.
As we come to the close of another year, we are excited to present eight research articles
in this issue. The research articles included in this issue are based on survey data and assess
the areas of Caffeine dependency, Codeine medications, Cervical cancer, Antibiotic resistance,
Mental health, Female contraception, and Vitamin supplements. Dylan Casey presents an
investigation into the prevalence of antibiotic resistant Vancomycin within Mercy University
Hospital. The knowledge, prevalence, and perception of sexually transmitted infections among
third level students is detailed by McKenna et al. Another research article by Delahunty et al.
details the Human Papilloma Virus (HPV) vaccination and cervical screening programmes
used for young women in Ireland today.
Dymet et al. highlight the need for more information to be offered to women about
contraceptives. O’Brien et al. present a research project into determining the knowledge among
the general public of codeine containing medication. Morgan et al. delve into college induced
stress and mental health. Kelsey Hough and Ellen Faherty establish the health, personal and
social factors that influence the use of vitamin/supplements among college students in Ireland.
Finally, Buckley et al. explore the consumption of caffeine containing beverages by the Irish
population and investigate their self-perceived dependency on such products. These reviews
and research articles make for some very insightful reading.
The editorial board would like to acknowledge our adjunct editors and IUJHS founders
Dr. Lesley Cotter and Dr. Brigid Lucey from the Department of Biological Sciences MTU, and
Ms. Sinead Hanrahan and Ms. Therese Ahern from the MTU library. This team has spent many
hours of their lives working towards the IUJHS which has now been launched following receipt
of funding from the National Forum for the Enhancement of Teaching and Learning. The
editorial board is indebted to the IUJHS reviewer panel. We send our deepest thanks to our
expert and student reviewers, who so willingly gave their time and expertise to see
undergraduate work published. Their feedback was always constructive and in keeping with

the aims of the journal, fostering a positive learning environment. This publication would not
have been possible without many individuals, but especially our undergraduate peers. We thank
them for their submissions to the journal and their engagement with the review process – long
may this continue for our future issues.
Shane Cusack & Ruth Delahunty
December 2021

An Investigation into the Prevalence of Vancomycin-resistant
Enterococci within an Irish Hospital
Dylan Casey
Department of Biological Sciences, Munster Technical University, Bishopstown, Cork, Ireland.
Department of Microbiology, Mercy University Hospital, Grenville Place, Cork, Ireland.

ABSTRACT
Vancomycin-resistant enterococci (VRE) are well-recognised nosocomial pathogens that pose a
significant threat to public health. Associated with poorer clinical outcomes than their vancomycinsensitive counterparts, the prevalence of VRE in Ireland has increased in recent times, with the
European Antimicrobial Resistance Surveillance Network reporting that out of 29 countries, Ireland
demonstrated the highest rates of vancomycin resistance among invasive Enterococcus faecium isolates
between 2011 and 2014 (2011; 34.9%, 2012; 44.0%, 2013; 42.7%, 2014; 45.1%). Herein, we investigate
VRE prevalence in the Mercy University Hospital (MUH) – an acute care hospital in southern Ireland.
A total of 21 first-time VRE infections were identified over a 40 day period between January and March
2021, representing a prevalence of 24.7%. In addition, one vancomycin-sensitive linezolid-resistant
strain was isolated from an Intensive Care patient, and environmental analysis revealed the presence of
an extensive VRE reservoir, with isolates identified on a keyboard, bedside desk, and electricity bar of
a primary observation unit. We also highlight the actions taken – including staff training and surface
decontamination – to curb transmission of the pathogen and prevent a full-scale VRE outbreak
developing within the hospital.

KEYWORDS: enterococci, vancomycin-resistance, VRE, nosocomial infection, infection control.

INTRODUCTION
The bacterial genus Enterococcus, of the phylum Firmicutes, are a ubiquitous cohort of Gram-positive
bacteria that present a formidable challenge to public health (García-Solache & Rice, 2019). While they
normally reside in the gastrointestinal tract of humans and other mammals, enterococci have been
isolated from many extraenteric habitats, including beach sand, terrestrial vegetation, and bodies of
water (Byappanahalli et al., 2012). Indeed, Neely & Maley, (2000) have documented the survival of
Enterococcus faecium, Enterococcus faecalis, Enterococcus gallinarum, and Enterococcus
casseliflavus on both polyester and polyethylene surfaces, such as may be used in hospital privacy
curtains and splash aprons, respectively, for longer than 90 days. Isolates of E. faecium have also been
shown to remain viable on a 60% cotton-40% polyester blend, as would be encountered on lab coats
and scrub suits, for this same time period (Neely & Maley, 2000).
Enterococcal persistence in these environments is of particular concern when the ability of the organism
to cause disease is considered; although most species are commensal bacteria, some are implicated in
urinary tract infections, wound infections, and infective endocarditis, among others (Byappanahalli et
al., 2012; Iaria et al., 2005; Rajkumari et al., 2014; Selleck et al., 2019). Some species, most often E.
faecalis and E. faecium, are capable of causing severe bacteraemia – a condition characterised by high
mortality rates (up to 40%) in critically-ill patients (Alqarni et al., 2018; Leibovici, 1995; Rosselli Del

Turco et al., 2020). Given that the pathogen is intrinsically resistant to many first-line antibiotics (e.g.
β-lactams and aminoglycosides), treatment of enterococcal illness can be complex, often requiring the
use of sophisticated, novel antimicrobials (Kristich et al., 2014). Vancomycin, a glycopeptide antibiotic
that was discovered in the 1950s, initially provided an alternative means of treating multidrug-resistant
strains. This success was short-lived however, and vancomycin-resistant enterococci (VRE) were
isolated from several patients with end-stage renal failure in 1988 – heralding the birth of a new era in
the war against the pathogen (Griffith, 1984; Uttley et al., 1988).
Since then, VRE have become a well-established source of nosocomial infection, posing a significant
threat to patients in high-dependency settings such as transplantation units, oncology wards, and
intensive-care units (ICUs) (Austin et al., 1999; Uttley et al., 1988). Within hospitals, VRE carriage is
strongly correlated with an increased average length of stay (LOS) and a notably higher cost of
hospitalisation (Jung et al., 2014). For these reasons, prevention of nosocomial VRE infection is of
paramount importance and due consideration must be given to implement measures that are known to
curb transmission of the pathogen. Nonetheless, VRE outbreaks remain a problem in healthcaresettings, with Weterings et al., (2021) recently describing a hospital-wide vancomycin-resistant E.
faecium (VREfm) outbreak in The Netherlands that took over 2 years to control. In addition, a 2014
report by the European Antimicrobial Resistance Surveillance Network (EARS-Net) showed that of the
29 EU countries from which data was provided, only 4 countries – Iceland, Estonia, Malta, and Finland
– reported a complete absence of vancomycin resistance among invasive E. faecium isolates. Perhaps
of more concern, however, was that Ireland, at 45.1%, recorded the highest percentage of invasive
VREfm isolates out of all 29 countries. Furthermore, a longitudinal analysis by Mendes et al. (2016)
showed that between 2001 and 2014, Ireland reported the 3rd highest percentage (5%) of E. faecium
isolates among blood culture specimens, with only Turkey (5.6%) and Germany (6.1%) reporting a
higher mean figure for the 14 year period.
While much research regarding VRE prevalence has been conducted elsewhere in Europe, hospital
surveillance of the pathogen is not as prominent in Ireland particularly outside of Dublin. Recent studies
by Ryan et al. (2015) and Mcdermott et al (2018) have investigated VRE trends in Irish hospitals, but
these are limited to specific sample types (blood cultures) and wards (ICUs), respectively. Thus, the
current study seeks to provide a comprehensive analysis that is not confined to the aforementioned
factors, thereby generating an accurate picture – or snapshot – of VRE prevalence over a defined time
period. In addition to analysing clinical samples, environmental sampling was conducted in order to
elucidate the modes of transmission responsible for VRE infection and provide a means for limiting
VRE persistence and spread.

MATERIALS AND METHODS
Clinical analysis
Sample cohort
Between the 28th of January 2021 and the 9th of March 2021 a VRE prevalence study was conducted in
the Mercy University Hospital (MUH) (a 330-bed acute general hospital located in the inner city of
Cork, Ireland). The sample cohort included those from patients in which a VRE screen was specifically
requested (i.e. rectal swabs), in addition to microbiological investigations whereby the identification of
an enterococcus warranted a VRE investigation to be subsequently conducted. A total of 98 clinical
samples, comprising 18 different sample types, were submitted for analysis (abscess swabs, blood
cultures, bone fragments, drain fluids, ear swabs, epigastric fluids, faecal samples, finger swabs, groin
swabs, leg swabs, lesion swabs, penile swabs, rectal swabs, stoma swabs, ulcer swabs, urine samples,
vaginal swabs, and wound swabs). While most samples (n=78) were obtained from patients within the
MUH, some samples were from patients in other Cork-based medical practices, namely South Infirmary
Victoria University Hospital (SIVUH) (n=18), Hollyhill Medical Centre (n=1), and Shandon Medical

Centre (n=1). Duplicate positives (i.e. more than one positive result from the same patient) were
excluded from prevalence data, but were included in data relating to sample type (as some VRE carriers
submitted more than one positive sample type during the study, this data was included). Similarly,
where duplicate positives were obtained, antimicrobial susceptibility testing (AST) was only performed
on the initial positive sample in line with the hospital policy regarding the frequency of testing of VRE
isolates. Given that a large proportion of samples arose from repeated VRE screening of patients,
duplicate negatives were included in prevalence data. Patient names and identifiers were omitted in
accordance with the ethical approval granted for this study.
VRE screening samples (rectal swabs)
Rectal swabs were directly plated onto chromogenic selective agar (chromID VRE Agar, bioMérieux
SA, Marcy-l’Étoile, France) and incubated aerobically at 36°C for 48 hours. Plates were analysed twice
during this time period (at 24-hour intervals), and presumptive positive VRE were confirmed by
identification testing (GP card) and AST analysis (AST-P662 card) performed on the VITEK 2 Compact
analyser (bioMérieux SA, Marcy-l’Étoile, France). Plates with no visible growth after 48 hrs. incubation
were reported as negative and subsequently discarded. A purity check plate analysis, performed on
Columbia Blood Agar (Columbia agar + 5% sheep blood, bioMérieux SA, Marcy-l’Étoile, France), was
conducted for all VITEK samples. Purity check plates were incubated for 24 hours in the presence of
5% CO2 and examined for pure growth to ensure the absence of contaminating organisms that could
interfere with VITEK analysis.
Non-VRE screening samples
For non-VRE screening samples (i.e. those in which during the course of another microbiological
investigation an enterococcus was isolated), the protocol followed was similar to rectal swabs in that
suspect enterococci were cultured onto chromogenic agar and incubated under the same conditions.
Presumptive positive VRE colonies were then confirmed via identification and AST analysis on the
VITEK 2 Compact analyser. In addition, one vancomycin-sensitive isolate, obtained from an ICU
patient, also underwent VITEK analysis. For blood culture specimens specifically, initial VRE
identification was not performed on chromogenic agar, but rather on the BioFire FilmArray analyser
(BioFire Diagnostics, LLC, Utah, USA) (as per the hospital policy regarding the investigation of
positive blood culture specimens). VITEK confirmatory testing (identification and AST analysis) was
conducted on these specimens thereafter.
Confirmation of results
For all sample types, a positive case of VRE was defined as the presence of characteristic VRE growth
on chromogenic agar (or a positive FilmArray result in the case of blood cultures), in addition to a
positive confirmatory result on the VITEK 2 Compact analyser. The genetic mechanism of vancomycinresistance was determined for VRE isolates by using the VITEK 2 Compact’s inbuilt susceptibilitybased prediction of van genotypes, as described by Abele-Horn et al., (2006). For linezolid-resistant
isolates, confirmatory PCR testing was conducted in the National MRSA Reference Laboratory
(NMRSARL, St. James’s Hospital, Dublin, Ireland).
Environmental analysis
Environmental sampling was conducted on the 4th of March 2021 in a 5-bedded observation room within
the male surgical ward from which an atypically high number of clinical VRE isolates originated (Table
1). Based upon the layout of the room, which was compact with uneven surfaces, swabbing was deemed
the most appropriate sampling method (in line with the recommendations of Rawlinson et al., (2019)).
A total of 30 swabs from three distinct areas of the room were sampled namely the front desk area
(n=12), the patient bedding area (n=11), and the toilet area (n=7). All samples were collected using the
Copan Liquid Amies Elution Swab (eSwab) Collection and Transport System (Copan Diagnostics
Inc., Murrieta, CA, USA). To standardise the swabbing process, a uniform technique, as described by

Margas et al., (2013), was employed on all surfaces. All samples were refrigerated at 3°C for 24 hours,
and after this period were streaked onto chromID VRE Agar and incubated at 36°C for 48 hours. As
for clinical samples, plates were checked for evidence of growth twice during this time period (at 24hour intervals), and those with no visible growth after 48 hours were reported as negative and
subsequently discarded. For plates with mixed (i.e. presumptive VRE colonies in addition to at least
one unrelated colony) or sparse growth (i.e. ≤ 3 presumptive VRE colonies) after primary culture,
isolated presumptive VRE colonies were subcultured onto fresh VRE plates to eliminate contaminating
organisms and enhance VRE retrieval. Presumptive VRE colonies were then confirmed via
identification (GP card) and AST analysis (AST-P662 card) on the VITEK 2 Compact analyser. As for
clinical samples, a purity check plate analysis was conducted for all environmental samples that
underwent VITEK analysis. The gold-standard colony-forming unit count (CFU count) method was
used to estimate microbial abundance in primary cultures, with the degree of growth denoted by -, +,
++, +++, and ++++ (where ‘-‘ = no growth; ‘+’ = 1-100 CFU; ‘++’ = 101-200 CFU; ‘+++’ = 201-300
CFU; ‘++++’ = too numerous to count (TNTC) (>300 CFU)) (Hazan et al., 2012).
Infection prevention and control
The infection control measures that were implemented in response to this studies’ findings were based
on the guidelines set out by the Hospital Infection Controls Practice Advisory Committee (HICPAC)
as regards preventing the spread of vancomycin-resistance in the hospital setting (CDC, 1995).
Statistical analysis
Prevalence was calculated by using the following formula:
prevalence (%) =

𝑛𝑛𝑛𝑛. 𝑜𝑜𝑜𝑜 𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓−𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡 𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖

𝑛𝑛𝑛𝑛. 𝑜𝑜𝑜𝑜 𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠 𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎 (𝑒𝑒.𝑑𝑑.𝑝𝑝.)

x

100
1

, where e.d.p. = excluding duplicate positives.

Confidence intervals (CI) were calculated by using the binomial proportion confidence interval formula:
𝑝𝑝̂ (1 − 𝑝𝑝̂ )�
𝑝𝑝̂ ± 𝑧𝑧 ∗ �
𝑛𝑛 , where 𝑝𝑝̂ is the sample proportion, 𝑧𝑧 is the standard normal value for the CI
(1.96 for a 95% CI), and 𝑛𝑛 is the sample size.

Ethical approval

Ethical approval for this study was granted by the Clinical Research Ethics Committee, Cork (Review
reference number ECM 4 (q)).

RESULTS AND DISCUSSION
Clinical analysis
During the 40 day period between the 28th of January 2021 and the 9th of March 2021, a total of 98 clinical
samples were investigated, with 34 positive for VRE (n=21 first-time infections and n=13 duplicate
positives) (Table 1). Excluding duplicates (i.e. non-first-time infections), the prevalence of VRE in this
study was 24.7% (21 out of 85 specimens) (95% confidence interval (CI): 15.5%-33.9%). The
remaining 64 samples were either negative for bacterial growth or contained unrelated organisms or
vancomycin-sensitive enterococci. These data reveal a pronounced VRE reservoir within the patient
population and our findings are in line with those of Whelton et al., (2016) who conducted a similar
study in Cork University Hospital (CUH) and observed a VRE prevalence of 19.1% (67 out of 350
specimens) (95% CI: 14.1%-24.1%). Furthermore, of the 18 South Infirmary Victoria University
Hospital (SIVUH) samples analysed in our study, 3 were found to be VRE positive, with 2 of these

identified as first-time infections. Thus, in conjunction with the findings of Whelton et al. (2016), our
findings indicate that VRE carriage likely extends to a number of hospitals within the Cork region.
There was considerable variation in patient location at the time of VRE isolation, with isolates obtained
from patients in 7 different wards within the hospital, namely: the female medical ward, the general
inpatient ward, the geriatric ward, the ICU, the male medical ward, the male surgical ward, and the
semi-private ward (Table 1). The highest number of positive samples were identified in the ICU and
male surgical ward, which recorded 10 VRE isolates each. In both of these sample cohorts, 6 of the 10
(60%) positive samples were from patients with no history of VRE colonisation (i.e. first-time
infections). Five positive samples were obtained from the general inpatient ward, of which 4 (80%)
were first-time infections. Cumulatively, these findings indicate that patients in these wards are at an
increased likelihood of VRE colonisation, and that VRE carriage is dispersed throughout the hospital
as opposed to being confined to a particular location. Indeed, this observation is in line with Weterings
et al., (2021) who describe a VREfm outbreak in the Admiraal De Ruyter Hospital (The Netherlands)
that affected all but three wards. The high number of VRE isolates identified in the ICU is particularly
concerning given that VRE carriage is invariably associated with medical complications in vulnerable
patients (Se et al., 2009). However, this is not altogether surprising given that ICUs are at the epicentre
of several VRE outbreaks described in the literature (Hughes et al., 2019; Marom et al., 2020; Peta et
al., 2006), and while our study does not describe a full-scale VRE outbreak, a similar paradigm appears
to have emerged within the MUH.
Variation also existed in terms of the sample types from which VRE isolates were identified. The
majority of VRE isolates (16/34 or 47.1%) (95% CI: 30.3%-63.8%) were recovered from rectal swabs,
with wound swabs and urine samples accounting for four positive samples each (8/34 or 23.5%) (95%
CI: 9.3%-37.8%). Vaginal swabs and drain fluid samples accounted for two VRE isolates each, with
the remaining six VRE isolates being isolated from six different sample types (abscess swab, blood
culture, epigastric fluid, groin swab, penile swab, and stoma swab). The variety of positive sample types
re-emphasises the ubiquitous nature of the pathogen, and upon comparison of our data with Ulrich et
al., (2017), some differences can be noted: most importantly, the prevalence of VRE in blood cultures,
which in their systematic review accounted for 30.1% (141/468) of isolates – a ten-fold increase on the
2.9% (1/34) observed in our study. In addition to the marked difference in sample size, such discordance
may be explained by the variation in patient profiles and while our study involved the general patient
population, their review was confined solely to studies involving haematology/oncology patients. Thus,
it may be that these patients, often regarded as the most immunocompromised in the hospital setting
(Ruhnke et al., 2014), are at an inherently higher risk of VRE bloodstream infection (BSI) than the
general patient population – an observation that certainly warrants further investigation.

Table 1: VRE prevalence data obtained from clinical samples received in the Mercy University Hospital.

A&E

No. of samples
analysed
3

No. of VRE
isolated
0

No. of first-time VRE
infections
0

CCU

2

0

0

0

Female medical ward

3

1

1

33.3

General inpatient ward

7 (6)

5

4

66.7

Geriatric ward

2

1

1

50.0

ICU

37 (33)

10

6

18.2

Male medical ward

1

1

1

100

Male surgical ward

13 (9)

10

6

66.7

OPD

2

0

0

0

Other*

3

0

0

0

Paediatric ward

1

0

0

0

Semi-private ward

4 (1)

3

0

0

SIVUH

18 (17)

3

2

11.8

Urology ward

2

0

0

0

Total

98 (85)

34

21

24.7

Patient location

Prevalence (%)†
0

Where applicable, numbers in parentheses following the no. of samples analysed indicates the no. of samples analysed
excluding duplicate positives.
Note: A&E = Accident and Emergency; CCU = Coronary Care Unit; ICU = Intensive Care Unit; OPD = Outpatient
Department; SIVUH = South Infirmary Victoria University Hospital
† where prevalence (%) is the no. of first time VRE infections expressed in terms of the no. of samples analysed (excluding
𝑛𝑛𝑛𝑛.𝑜𝑜𝑜𝑜 𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓 𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡 𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖
100
duplicate positives (e.d.p.)) i.e. prevalence (%) =
x
𝑛𝑛𝑛𝑛.𝑜𝑜𝑜𝑜 𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠 𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎 (𝑒𝑒.𝑑𝑑.𝑝𝑝.)

1

* includes samples from Mercy Private Corridor, Hollyhill Medical Centre, and Shandon Medical Centre.

Environmental analysis
Owing to the high number of VRE isolated from patients in the male surgical ward, environmental
swabbing of the ward’s primary observation room was conducted in order to investigate the presence
of an environmental reservoir (Table 2). Three areas of the observation room were swabbed, resulting
in a total of 30 swabs submitted for analysis. The front desk area, from which 12 swabs were obtained,
was found to harbour VRE contamination in one site, namely the keyboard. Seven environmental swabs
were taken from the toilet area, with none of these showing evidence of VRE contamination. Of the 11
sites swabbed in the patient bedding area, two were positive for VRE, namely the electricity bar and
bedside desk of bedding area 2. In total, three of the 30 (10%) environmental swabs analysed in this
study were VRE contaminated. These findings are strongly suggestive of an active environmental VRE
reservoir within the primary observation room of the male surgical ward.
In contrast to the sparse VRE growth observed upon primary culture of the keyboard and electricity bar
swabs (1 CFU each), a near-confluent lawn of VRE growth was demonstrated upon primary culture of
the bedside desk swab (CFU = too numerous to count (TNTC)) (Table 2). Although the CFU method
may not be as accurate as a microscopic cell count, for example, it does allow for an estimate of
microbial abundance in an environmental sample (Andrés Christen & Parker, 2020; Cundell, 2015). In
this regard, it can be assumed that of the three positive environmental swabs, the bedside desk of

bedding area 2 carried the highest VRE burden. The significance of this observation is underpinned by
the fact that at the time of sample collection, this patient bedding area was vacant and presumably
awaiting the admission of a new patient, who, given the high environmental VRE load, would have
been at an increased likelihood of becoming colonised by the pathogen. Coupling this with the
identification of VRE isolates on the electricity bar, it is evident that the cleaning protocol utilised
following the discharge of the previous patient failed to eradicate residual VRE. Indeed, it is plausible
to hypothesise that this VRE reservoir existed for a considerable period of time and may have been a
source of infection prior to this study. As such, our results do not represent a novel find and VRE
contamination of these sites is to be expected when prevalence rates among patients are high.
The identification of VRE isolates on the keyboard is noteworthy given the frequency of its use by
hospital staff. Indeed, keyboard contamination is somewhat unsurprising as Schultz et al.(2003) report
that of the 100 keyboards tested in their hospital-wide study, 95 (95%) were positive for
microorganisms. Moreover, while most of these isolates were commensal-skin flora, four of the isolates
were enterococci, of which one was vancomycin-resistant. Similar rates of keyboard contamination
have also been reported by Nazeri et al., (2019), with microbes being identified on more than two-thirds
(76%) of the keyboards and electronic devices analysed in their cross-sectional study. Thus, it is clear
that keyboards represent a potential source of nosocomial infection in many hospitals and our findings
suggest the MUH cannot be considered an exception. Furthermore, while the keyboard analysed in our
study is confined to the primary observation room, the frequency of its use by doctors and nurses,
estimated to be 8.6 times/hour in one study, could facilitate VRE dissemination to distant areas within
the hospital (Hong et al., 2012).
The absence of VRE contaminants in the toilet area was largely unexpected, particularly given that the
toilet within the observation room is a communal facility; at any one time up to 5 patients may share its
use. In other studies, VRE isolates have been identified in hospital toilets, with Ulrich et al., (2017)
stressing that a special emphasis need be placed on toilets with respect to environmental VRE
disinfection. Thus, our findings may indicate that the shared toilet facility within the observation room
is, unlike other areas of the room, adequately cleaned as to prevent VRE persistence.

Table 2: Environmental sampling data obtained from the primary observation room of the male surgical
ward.
Site of swab
Door handles

VRE present (Y/N)

Degree of VRE growth in primary culture†

Front desk area
N

Telephone

N

Keyboard

Y

Chair armrest

N

Computer mouse

N

Bloodtrack devices

N

Light switches

N

Sink taps

N

Soap dispensers

N

Drawer handles

N

Monkey bar (4)

N

Remote control

N

+
-

Toilet area
Sink taps

N

Door handles

N

Toilet handle

N

Soap dispensers

N

Support rail

N

Toilet bowl surface

N

Paper towel holder

N

-

Patient bedding area
Chair armrest (1)

N

Table at end of bed (1)

N

Walking frame (1)

N

Windowsill

N

IV fluid holder (1)

N

Blood pressure monitor (1)

N

Electricity bar (2)

Y

Bed front railings (1)

N

Bed back railings (1)

N

Bedside desk (1)

N

Bedside desk (2)

Y

+
++++

Where applicable, numbers in parentheses following a swabbing site indicate which patient bedding area the swab was taken
from.
† where ‘-‘ = no growth; ‘+’ = 1-100 CFU; ‘++’ = 101-200 CFU; ‘+++’ = 201-300 CFU; ‘++++’ = too numerous to count
(TNTC) (>300 CFU)

Antimicrobial susceptibility testing
For all first-time VRE infections and positive environmental specimens, identification testing was
performed to provide a species-level resolution of the isolated enterococci. Antimicrobial susceptibility
testing (AST) was also conducted in order to elucidate the patterns of antimicrobial resistance present
within the VRE population (Table 3). In addition to the 24 VRE, one vancomycin-sensitive strain
(subsequently found to be linezolid-resistant), isolated from a wound swab of an ICU patient, was also
subject to identification and AST testing. All 24 presumptive positive VRE identified by culture (21
clinical and 3 environmental) were confirmed to be vancomycin-resistant by AST testing, with
minimum inhibitory concentration (MIC) values of >16µg/mL reported for all isolates. Furthermore, in
agreement with Whelton et al. (2016), all isolates (n=24 VRE and n=1 VSE) investigated in our study
were identified as E. faecium (with VITEK identification probabilities ranging from 86%-98%),
implicating this species as the predominant nosocomial strain. As regards the mechanisms of
vancomycin-resistance, all isolates demonstrated the vanA genotype. Although confirmatory
polymerase-chain reaction (PCR) testing of van genotypes was not performed in our study, Abele-Horn
et al., (2006) report that 98.5% (65/66) of PCR-confirmed E. faecium vanA strains are correctly
characterised by the VITEK 2 system. Thus, it can be assumed that the majority, if not all, of the tested
VRE isolates were accurately characterised as vanA. In line with this, a key characteristic of vanA
subtypes, high-level teicoplanin resistance (MIC >16µg/ml), was observed in all VRE isolates (Qu et
al., 2009).
Consistent with the findings of Engin et al. (2013) and Whelton et al. (2016), ampicillin-resistance was
observed in all isolates (MIC >16 µg/mL), indicating the widespread prevalence of an ampicillinresistant VRE phenotype in the patient population. As regards antimicrobial synergism, the synergy
between a cell wall active agent (e.g. ampicillin) and an aminoglycoside (e.g. streptomycin) is best
predicted by screening for high level resistance to the aminoglycoside (Torres et al., 1995). As such,
the susceptibility of isolates to gentamicin, kanamycin, and streptomycin was investigated, with results
showing considerable variation between the three agents. With respect to gentamicin, all but two
isolates were shown to exhibit high-level resistance to the antibiotic. Interestingly, one of the susceptible
isolates was recovered from a drain fluid sample of a patient located in the male surgical ward and
further analysis revealed the entire AST profile of this isolate to be an exact replicate of that obtained
from both the keyboard and electricity bar (n=2) isolates however, more sophisticated methods, such as
the gold standard pulsed-field gel electrophoresis (PFGE) (Salipante et al., 2015), would be required to
conclusively determine the relatedness of these three strains.. Kanamycin resistance was observed in all
but one VRE isolate, indicating that synergistic combinations which incorporate kanamycin as an
aminoglycoside no longer represent an option for VRE treatment in the MUH. In contrast, susceptibility
to streptomycin varied among isolates, with 37.5% (9/24) observed to be resistant, and 62.5% (15/24)
remaining susceptible. Hence, of the three aminoglycosides investigated in this study, streptomycin
offers the greatest potential as a therapeutic against VRE, and may still be considered for treatment of
VRE infection against which other treatments have been exhausted.
Linezolid has been approved by the FDA for treatment of VREfm infections which are unresponsive to
first/second-line antimicrobial therapy (Hashemian et al., 2018). Commonly referred to as a ‘last-resort
antibiotic’, the use of linezolid is typically reserved for cases of severe infection whereby the causative
agent is multi-drug resistant (Sadowy, 2018). Given this status, it is concerning that one of the
enterococci identified in our study was linezolid-resistant. An MIC value of >4 µg/mL was reported,
with the specimen subsequently being referred to a specialist centre (National MRSA Reference
Laboratory (NMRSARL)) for confirmatory MIC testing and PCR analysis. MIC testing conducted in
the NMRSARL revealed an MIC value of 8 µg/mL (via broth dilution), and PCR analysis did not detect
the presence of the transferrable resistance genes cfr, optrA, and poxtA. These resistance determinants,
which are often nested within plasmid-borne mobile genetic elements (MGEs), are easily transferred
between bacteria and have the potential to mediate the widespread dissemination of linezolid-resistance
(Bender et al., 2019). The failure to detect these genes via PCR indicates that linezolid-resistance in
this isolate is governed by an alternative mechanism: most likely a mutation in bacterial ribosomes
and/or associated ribosomal proteins (Ruiz-Ripa et al., 2021). Given the non-transferable nature of these

mutations, it is unlikely that the isolate represents a real threat in terms of resistance dissemination.
Furthermore, while a clear linezolid-resistant phenotype was identified, the isolate was susceptible to
vancomycin, demonstrating an MIC value of <0.5µg/mL. Nonetheless, the identification of this isolate
highlights the need for strict antimicrobial stewardship to prevent a vancomycin-resistant linezolidresistant phenotype emerging in the patient.
Tigecycline and quinupristin-dalfopristin were the only two antibiotics against which all of the isolated
VRE were susceptible. While these data are encouraging, it is important to note that the high rate of
quinupristin-dalfopristin susceptibility is likely a reflection of the sole isolation of E. faecium species
in our study. More precisely, although the rates of resistance to quinupristin-dalfopristin are low among
strains of VREfm, the converse is true for vancomycin-resistant E. faecalis, with only 3.2% of isolates
remaining susceptible according to one study (in contrast to 90.6% of VREfm) (Eliopoulos, 2003). Thus,
while quinupristin-dalfopristin therapy may be indicated for most VRE infections arising within the
MUH, this may not be the case with respect to infections in patients travelling from areas such as
Northern and Eastern Europe where vancomycin-resistant E. faecalis is more prominent (Ayobami et
al., 2020).
Table 3: VITEK 2 Compact antimicrobial susceptibility testing (AST-P662 card) on presumptive positive
vancomycin-resistant enterococci recovered from first-time infections and environmental samples.
Antimicrobial

No. of isolates
tested*

No. of isolates
susceptible

No. of isolates
resistant

Likely to be
effective †

Ampicillin (AMP)

24

0

24

❌

Gentamicin (GEN)

24

4

20

❌

Kanamycin (KAN)

24

1

23

❌

Linezolid (LZD)
QuinupristinDalfopristin (Q/D)
Streptomycin (STM)

24

24

0

✅

24

24

0

✅

24

15

9

✅

Teicoplanin (TEI)

24

0

24

❌

Tigecycline (TIG)

24

24

0

✅

Vancomycin (VAN)

24

0

24

❌

† where the majority of isolates were found to be susceptible an antibiotic was considered ‘likely to be effective’
* the linezolid-resistant isolate also underwent AST analysis but was vancomycin-sensitive and so was excluded from the
above-shown data. This isolate had the following resistotype: AMP-GEN-KAN-LZD.

Infection prevention and control
In the context of pathogen containment, an emergency meeting was conducted in April 2021 in order
to address the findings of this study. Many of the topics discussed are in line with the guidelines set out
by the Hospital Infection Controls Practice Advisory Committee (HICPAC) as regards preventing the
spread of vancomycin-resistance in the hospital-setting (CDC, 1995). These guidelines, which require
a coordinated interdisciplinary approach, are comprised of four core elements: a) the prudent use of
vancomycin by clinicians, b) education of all hospital staff regarding the impact of VRE, c) early
detection and reporting of VRE by laboratory staff, and d) the prompt implementation of infection
control measures to prevent person-person VRE transmission (CDC, 1995).
Regarding vancomycin usage, it has been estimated that in an estimated 34-67% of cases, its use could
be considered inappropriate, with methicillin-resistant Staphylococcus aureus (MRSA) being cited as a
contributory factor in many hospitals (i.e. use of vancomycin to treat MRSA often favours the
emergence of VRE) (Junior et al., 2007). While neither the prevalence of MRSA nor the frequency of

vancomycin use were investigated in our study, our findings highlight the need for prescribing clinicians
to adopt a cautious approach moving forward.
Education of hospital staff, in particular nurses and other ward-level personnel, on the significance of
VRE was an obvious requirement given the high number of first-time infections arising in many wards.
The importance of proper hygiene was relayed to the relevant staff, with an emphasis on handwashing
technique, use of personal protective equipment (PPE), and surface disinfection (Mutters et al., 2013).
As regards the environmental reservoir, the seriousness of the issue was highlighted and the use of a
plastic keyboard cover in tandem with frequent disinfection was implemented (Hong et al., 2012).
Given that the microbiology laboratory serves as the first-line of defense against VRE spread in the
hospital setting (CDC, 1995), laboratory staff play a central role in breaking the chains of pathogen
transmission. With a view to ensuring patient-patient and patient-staff VRE transmission is minimised
within the hospital, the need for prompt identification and reporting of VRE-positive patients was
reiterated to microbiology staff. In addition, the continued monitoring of VRE prevalence was
recommended to allow for the early-identification of VRE clusters emerging at the ward-level.
Limitations
This study had a number of limitations. Firstly, although the study was conducted over a considerable
time period, the sample size (n=98) was relatively small. Secondly, owing to a lack of resources and
financial constraints, molecular typing of VRE isolates was not performed in this study. Although an
attempt was made to determine the relatedness of strains by comparison of AST profiles, this cannot be
considered an adequate substitution for molecular methods such as PFGE and multilocus sequence
typing (MLST).
Using PFGE, Ryan et al. (2015) determined the clonal relatedness of VRE strains obtained from patients
within St. Vincent's University Hospital (SVUH), allowing them to decipher the epidemiological links
between many of the isolates and establish the likely starting points for several clusters of infection.
Thus, it is clear that molecular typing adds an extra dimension to prevalence data and should be
incorporated into future studies. Finally, given that only three areas in the primary observation room of
the male surgical ward were sampled, it is likely that the VRE burden within this area, if not the entire
ward, is greater than our results imply. In addition, environmental sampling of other wards from which
high numbers of first-time infections were reported, such as the general inpatient ward and the ICU, is
needed to determine if VRE reservoirs exist in these areas.

CONCLUSION
In summary, the findings described herein reveal high rates of VRE carriage among patients within the
MUH, while also pointing towards the presence of an active environmental reservoir in the male
surgical ward. In line with other Irish studies (Morris-Downes et al., 2010; Ryan et al., 2015; Whelton
et al., 2016), vanA VREfm appears to be the predominant nosocomial strain, with linezolid-resistance
still a cause for concern. It is hoped that this study highlights the ongoing threat posed by VRE in the
hospital setting and may, at least in part, help to explain why Ireland continues to surpass its neighbours
in terms of VRE prevalence.
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ABSTRACT
Background: Sexually transmitted infections (STIs) are transmitted through sexual contact with an
infected person and these infections are capable of causing health problems such as infertility. In
Ireland, the majority of STIs have been on the increase since the early 2000s, particularly among young
people aged 15-24 years old.
Aims: The aims of this study were to investigate the knowledge, prevalence and perception of thirdlevel students in Cork, Ireland regarding STIs.
Methodology: The survey created using Google Forms™ was distributed to registered students of
University College Cork (UCC) and Munster Technological University, Cork (MTU). The questions
were constructed based on similar surveys included in peer-reviewed papers. Ethical approval was
received prior to commencing this survey. The collected data was statistically analysed via Microsoft
Excel.
Results: A total of 709 anonymous, valid and voluntary responses were collected. Eighty-five percent
of respondents had received sexual health education at secondary school. Of 709 respondents, 673
(94.9%) believed that unprotected sexual activity could lead to acquiring STIs. Over half (56.1%) of
sexually active respondents were unaware of free STI testing available on both university campuses.
Conclusion: The majority of third-level students felt that their sexual health education was limited. The
respondents lacked ample knowledge on the topic of STIs and were incapable of correctly answering
all of the survey's questions.

INTRODUCTION
Sexually transmitted infections (STIs), as defined by the Health Service Executive (HSE) (n.d.), are
infections passed on through sexual contact with someone who is infected. As reported by the Word
Health Organisation (WHO), more than thirty different bacteria, parasites and viruses are known to be
transmitted through sexual contact, the majority of which cause asymptomatic infection (WHO 2019).
Furthermore, female and male reproductive tract morbidities such as infertility are attributable to
untreated STIs (Tsevat et al., 2017). Chlamydia and gonorrhoea are the most common STIs in Ireland,
both of which can cause infertility if left untreated (HPSC 2021).
In Ireland, there has been a trending increase in STI notification rates for chlamydia, gonorrhoea and
genital herpes since the early 2000s (HSPC 2019). Young people under 25 years of age constitute a
significant proportion of new STI diagnoses and are an area of focus when it comes to reducing STI

transmission (Department of Health and Healthy Ireland 2019). According to a UNESCO study (2015),
comprehensive sexual health education has the ability to contribute to the reduction of STIs.
Furthermore, a study conducted by Lally et al., (2015) concluded that young people in Ireland possess
insufficient knowledge on the prevention, transmission and treatments of STIs. Our study sought to
investigate the knowledge, prevalence and perception of third-level students in Cork, Ireland regarding
STIs. There was an additional focus on whether or not the knowledge of students had improved since
the publication of Lally et al’s., report from 2015.

METHODOLOGY
Study Design
Peer-reviewed papers, such as Lally et al., (2015), were consulted to assist in the construction of the
survey. Google Forms™ administration software was applied in creating the survey. The survey
contained a total of twenty-five questions. Closed and open-ended questions relating to participant
demographics, sexual activity and knowledge of sexually transmitted infections (STIs) were asked. The
Likert scale was applied where appropriate within the survey as a means of psychometric analysis of
the respondents on certain issues relating to STIs.
A focus group study was conducted whereby the survey was distributed to twenty-four third-level
students of Munster Technological University (MTU) and University College Cork (UCC). The
suggestions obtained from this focus group study were incorporated into the final survey. The comments
and responses were not included in the final findings.
Ethics
Ethical approval had been sought and received from the coordinators of the BIOL8024: Research and
Professionalism module who acted on behalf of the MTU Research Ethics Committee (REC). The
nature of participation was voluntary and informed consent was obtained from participants at the
beginning of the survey. Responses were anonymous and kept confidential. Acquired data was
downloaded and stored on password-protected electronic devices only accessible to the authors of this
paper. The data will be deleted within five years.
Survey Population
Students of UCC and MTU were chosen as the target population for this study. These are the two largest
third-level institutions in Cork, Ireland, which ensured that a large proportion of third-level students in
County Cork would be reached. It was estimated that approximately 22,500 students received the survey
via email. Students from Post Leaving Certificate (PLC) colleges in Cork were excluded as there was
no point of contact in these colleges to enable distribution of the survey.
Survey Distribution and Implementation
The finalised survey was distributed via UCC’s survey service, surveys@ucc.ucc.ie to registered and
subscribed students of University College Cork, Ireland on 2 March 2021. The survey was made
available to registered students of MTU, Cork to complete through academic staff who forwarded the
survey to their class groups. The survey was also shared with several undergraduate class
representatives from different College Departments of UCC who were asked to distribute the survey to
their class group-chats via WhatsApp, Snapchat and Facebook Messenger. Informed consent was
sought from participants at the beginning of the survey and those who did not consent had their
responses invalidated. Anonymous and confidential responses were submitted. The survey was closed
on 21 March 2021.

Data Analysis
Participant responses were analysed using Google Forms™ and the responses automatically recorded
in the attached Google Sheets. The responses in Google Sheets were downloaded in a format accessible
to Microsoft Excel which was subsequently used for statistical analysis. In Microsoft Excel, the
collected data was analysed using the “Analysis Toolpak” add-in under the “Data” tab. By using this
feature, pivot tables, frequency tables and pivot charts were constructed. Close-ended questions were
displayed in figures and tables using the graph function in Excel for clear presentation of results. Openended questions were analysed by reading through the answers individually to find similarities and were
discussed in-text.

RESULTS
Respondent Demographics
The survey was completed by 713 respondents of which 4 responses were invalidated as the participants
either did not consent to their participation in the survey or did not answer questions appropriately and
thus were excluded from analysis,. Of the 709 valid responses, 489 (69.0%) were female, 205 (28.9%)
were male, 13 (1.8%) were non-binary, and the remaining 2 (0.3%) responses did not indicate their
gender. A total of 606 (85.5%) respondents were within the ages of 18-24 years old, 49 (6.9%) were
aged 25-29 years old, and 54 (7.6%) were older than 30 years old. Students in Science, Engineering and
Food Science represented the largest portion of respondents, at 223 (31.5%) students. Two hundred and
three (28.6%) students were in Arts, Celtic Studies and Social Sciences, 150 (21.2%) students were in
Medicine and Health, 114 (16.1%) students were in Business and Law, with the remaining 19 (2.7%)
students in Education. All respondents were registered students of UCC or MTU, Cork. Five hundred
and fifteen of the 709 respondents (72.6%) indicated that they were sexually active.
Sexual Health Knowledge
The large majority (85%) of respondents had received sexual health education at secondary school or
in some other form. Furthermore 529 (87.3%) students aged 18-24 years old, and 42 (85.7%) students
aged 25-29 years old had received sex education compared to only 32 (59.3%) students aged over 30
years old. Of those who had received sexual health education 456 (75.6%) felt they had an average to
very poor understanding of STIs, while only 147 (24.4%) respondents felt they had very good or good
knowledge regarding STIs.
In Figure 1 are the seven options presented to the participants, from which they were asked to identify
which activities can transmit STIs. Vaginal sex, anal sex, oral sex, sharing sex toys, kissing and skinto-skin contact were the options provided that are capable of transmitting STIs, while use of shared
bathrooms was an activity through which they could not acquire an STI. Of the 709 respondents, 707
(99.7%) could identify at least one activity through which STIs are transmitted. However, only 106
(15%) respondents correctly identified all activities through which someone can acquire an STI.

Figure 1: Suggested STI transmitting activities and the percentage of respondents that believed these
activities were capable of transmission.

When asked to choose methods that prevent transmission of STIs, 675 (95.2%) respondents chose
condoms, 550 (77.6%) chose abstinence, 310 (43.7%) chose dental dams, 164 (23.1%) chose
vaccination and 159 (22.4%) chose pre-exposure prophylaxis (PrEP). Thirty-six (5.1%) respondents
incorrectly identified the oral contraceptive pill, IUD/Implant or tubal ligation/vasectomy as a method
to prevent transmission.
Figure 2 highlights the responses from the 709 participants relating to which STIs they think can be
treated with antibiotics. Only 198 (27.93%) could correctly identify the three STIs in the list which have
antibiotic treatments. Six hundred and thirty-five (89.56%) of the respondents chose a combination of
STIs in which at least one is treatable by antibiotics and 34 (4.8%) believed that HIV was an STI which
could be treated by antibiotics. Seventy (46.6%) Medicine and Health Science students correctly
identified the three STIs treated with antibiotics, while less than 27% in the other University
Departments correctly identified the three STIs treated with antibiotics.

Figure 2: The percentage of respondents who thought STIs could be treated with antibiotics.

Following this, 125 (17.6%) of those asked correctly identified all the STIs which are manageable but
have no cures and are lifelong. Six hundred and sixty-one (93.2%) respondents of the 709 who answered
the question asking whether STIs always produce symptoms correctly identified that symptoms are not
always present.
Of the 515 sexually active respondents, 289 (56.1%) were not aware of free STI testing on the university
campuses. Only 226 (43.9%) of the sexually active students were aware of free STI testing on both
campuses.
Prevalence of Sexually Transmitted Infections (STIs)
Of the 709 respondents, 243 (34.3%) at one point had an STI test. Furthermore, 224 (43.5%) sexually
active respondents seek STI tests, while only 19 (9.8%) sexually inactive respondents would. As
displayed in figure 3, of the 243 respondents who had an STI test, 76 (31.3%) had been diagnosed with
one or more STIs. The majority of respondents had been diagnosed with chlamydia (59.2%). This was
followed by genital herpes (21.1%) and genital warts (14.5%). Five respondents (6.6%) indicated other
reported STIs such as human papillomavirus (HPV), molluscum contagiosum, pubic lice and
trichomoniasis. The incidence of STIs among the total population of 709 respondents is 10.7%.

Figure 3: The number of reported sexually transmitted infections (STIs) among the respondents who had
positively tested for one or more STIs

Four hundred and eighty (93.2%) sexually active respondents admitted to having used contraceptives
of some type when sexually active. Where these respondents could choose more than one option, of
480 responses this was mainly to prevent pregnancy (91.7%), to prevent STIs (48.8%), for medical
reasons (9.4%), or at the request of a partner (5.4%).
Where sexually active respondents used contraceptives of one form, condoms followed by the oral
contraceptive pill were most common. These were followed by contraceptive implants and the
withdrawal method. Where a combination of contraceptives were used by respondents, condoms and
the oral contraceptive pill were most popular, with 91 of 480 respondents using both forms.

Six hundred and seventy-three (94.9%) of 709 respondents believed that unprotected sexual activity
could lead to the contraction of STIs. The majority (60.4%) of the 515 sexually active respondents
would always, frequently or sometimes discuss their sexual health status with sexual partners.
Perception of STIs
When asked where the respondents acquired their information on STIs, a wide variety of responses
were obtained, the most prevalent answer being the internet, of which 574 respondents (81%) chose as
a method of acquiring information on STIs. Of the 709 respondents, 109 of them (15.4%) chose the
internet as their sole source of acquiring information. Other popular responses included friends (46.3%),
school sex education (46.1%), healthcare professionals (34.1%), books/magazines (18.6%) and family
(12%). Other, less common sources disclosed included TV programmes, college course content,
scientific journals and by experience.
When the respondents were asked about STI testing, 389 (57%) would seek an STI test upon
experiencing symptoms with 149 of respondents stating this as their sole reason for seeking an STI test.
Two hundred and sixty-four (38.7%) respondents would seek an STI test after changing a sexual partner.
Other responses as summarised in figure 4 included after engaging in unprotected sex (35.7%), regular
check-ups (24.8%) and after each sexual encounter (3.8%). Thirty-seven respondents (5.4%) disclosed
they would never seek an STI test.

Figure 4: Percentage of respondents and reasons for seeking an STI test.

DISCUSSION
The current study was inspired by a previous investigation conducted by Lally et al., (2015) into female
and male Irish university students’ awareness and knowledge of sexual health and STIs. According to
McBride et al., (2010), the median age of Irish women’s first sexual encounter is 18 and Irish men’s
first sexual encounter is 17, which suggests a significant proportion have not yet engaged in sexual
behaviour when entering third-level education. This emphasises the importance of assessing whether
third-level students are equipped with adequate knowledge to practice safe sex.
The majority of respondents (85%) had received sexual health education in secondary school, with one
interesting finding being that 87.3% of students aged 18-24 years old had received sexual health
education compared to 59.3% of students older than 30 years old. Overall, the percentage of people
who received sexual health education in secondary school has increased from 74.2% in 2015 to 85% in

2021 (Lally et al., 2015). During the same period there was increased recognition of condoms as being
preventative against STI acquisition . A possible explanation for the disparity in education between
younger and older students may be the publishing of the relationship and sexuality education (RSE)
Framework in 2000 and 2011 (Keating et al., 2018). However, the effective implementation of RSE at
second-level education varies among secondary schools (Keating et al., 2018).
The quality of the education received varied among the respondents, with most students (75.6%) who
received sexual health education at secondary school level feeling their education was only average or
below when it came to an understanding of STIs. This finding highlighted the students' recognition of
their lack of knowledge regarding STIs, which is reflected in the incidence of STIs in this study being
10.7% and is relatively consistent with the 10.3% reported in a previous study of university students in
Ireland (Lally et al., 2015). Students’ descriptions of their education detailed the lack of depth, an
emphasis on reproduction, and an absence of LGBTQ+ topics. In fact, this education did not reflect
young people’s priorities with them seeking information from the internet on sexual pleasure, STIs,
communication skills with partners, and pregnancy (McCarthy et al., 2012). This suggests a failure of
secondary school sexual health education to not only meet the priorities of students but to also provide
a comprehensive education regarding STIs.
Fact-based questions surrounding treatment of STIs were asked to assess how much third-level students
knew about common and circulating STIs. Only 198 (27.93%) could correctly identify the three STIs
in the list which have antibiotic treatments. This highlighted that the majority of students are unaware
of the treatment options for common STIs. Six hundred and thirty-five (89.6%) students could however
identify at least one antibiotic treatable STI, with chlamydia being chosen the most frequently (84.9%).
Medicine and Health Science students were the most likely to correctly identify which three STIs are
treated with antibiotics, with 70 (46.6%) choosing correctly compared to less than 27% in the other
University Departments. This finding is consistent with a previous study involving the STI knowledge
of students aged 17-20 in Pulau Pinang, Malaysia, which found that science students were more
knowledgeable on the topic of STIs than Arts Department students (Anwar et al., 2010). This finding
was expected as students in Medical and Health Science courses are taught about STIs and potential
treatments as part of their field of study, while other University Departments are not.
To further test their knowledge on STIs, the respondents were asked which STIs from a list were
manageable but not curable. Six hundred and eighty-six respondents could correctly choose at least one
STI from the list which fit these criteria, however only 17.6% could correctly identify all three,
suggesting that most respondents were not fully aware of the life-long consequences of common STIs
in Ireland. The questions asked throughout the study were chosen to assess how much knowledge thirdlevel students have regarding STIs. This study revealed that the majority of students do not have a
substantial amount of sexual health and STI knowledge. This finding is worrying as the information
regarding which STIs are the most prevalent, their symptoms and treatments are imperative in
controlling STIs (HSE, 2018).
It was determined that 515 (72.6%) participants of 709 were sexually active with 480 of those using
contraceptives of some form. The primary reason for contraceptive use by the majority of respondents
was for avoiding inadvertent pregnancy rather than for the prevention of STIs. However, when asked,
the majority of total respondents believed that unprotected sex could result in an STI. According to the
HSE’s ‘Your Guide to Sexually Transmitted Infections (STIs)’ (n.d.), barrier methods such as condoms,
including female internal condoms and male external condoms, can reduce the risk of contracting STIs
significantly when correctly applied. Moreover, the Centres for Disease Control and Prevention (CDC)
states that while hormonal or long-acting reversible methods and sterilisation are effective at avoiding
conception, they neither prevent nor protect from STIs during sexual activities (CDC 2020). However,
when asked which contraceptive methods can reduce STI contraction and transmission, only 36 (5.1%)
of total respondents answered incorrectly by choosing the oral contraceptive pill, implanted
contraceptive and/or tubal ligation/vasectomy. This demonstrates that respondents are aware of which
contraceptives do not reduce the risk of acquiring STIs.

To investigate the prevalence of STIs among third-level students, participants were asked whether they
had an STI test at some point in the past, in which only 224 (43.5%) of 515 sexually active respondents
had one. This implies that the majority of respondents who are sexually active do not seek STI tests.
However, when asked whether respondents discuss their sexual health status with sexual partners, the
majority (60.4%) of the 515 sexually active respondents would always, frequently or sometimes do so.
Chlamydia, genital herpes, genital warts and/or gonorrhoea were commonly reported in those who had
positively tested for one or more STIs following a test. This finding was similar to the Health Protection
Surveillance Centre’s annual report on STIs in Ireland from 2020 where chlamydia was reported as the
most common STI (HPSC 2021). However, where genital herpes was the second most reported STI in
this study, it was gonorrhoea that was the second most reported nationally in 2020 (HPSC 2021). It
seems that although the majority of third-level students are aware of STIs and take the necessary
precautions to prevent contraction and transmission, the burden of STIs falls most heavily on young
people, with people less than 30 years of age accounting for 63.4% of new STI diagnoses in 2020
(HPSC 2021).
Another important but worrying finding was that over half (56.1%) of sexually active respondents were
not aware of free STI testing available on both campuses. This finding was discouraging and highlighted
the need for improved advertising on campuses in relation to their free STI testing services. When asked
what would encourage students to avail of STI testing, most respondents suggested that the stigma
associated with STIs needed to be reduced. This is consistent with a previous investigation carried out
in 2020 by Vaughan et al., in which a qualitative study was conducted on the experiences of stigma in
healthcare settings by people living with HIV in Ireland.
This study highlighted the overall poor perception that third-level students in Cork have on STIs. The
large majority of respondents admitted using the internet and/or their peers as sources of information
for STIs. This can lead to false information about STIs as the internet is not always a reliable source of
information. Only a minority (34.1%) of respondents disclosed acquiring their information from
healthcare professionals. These results reflect those of Lally et al., (2015) in which it was reported that
the majority of respondents seek their sexual health information from the internet followed by their
peers and subsequently healthcare professionals at only 31% of respondents.
Of 661 respondents that think a person infected with an STI does not always show signs and/or
symptoms, 149 of them said they would only seek an STI test upon experiencing symptoms. There are
similarities between the attitudes expressed by these respondents in this study and those described by
Balfe and Brugha (2009) in which many respondents delayed seeking testing. Reasons outlined by Balfe
and Brugha included respondents' concerns about stigma and that they would be judged by healthcare
professionals, and also feelings of vulnerability.

LIMITATIONS
These findings may be somewhat limited in their representation of the third-level student population in
Cork, Ireland as 709 responses do not fully represent the entire student population of over 37,000
students in Cork City (MTU 2021; UCC 2021).

CONCLUSION
The sexual health education that the respondents received throughout their lives was insufficient, and
as a consequence of this, they had an inadequate amount of knowledge on the topic of STIs. Although
there have been better efforts made in educating students at second-level over recent years, the incidence

of STIs among third-level students remains relatively high. This merits further investigation as to the
failed implementation of knowledge by third-level students.
Further work should focus on investigating the knowledge of STIs nationally across Ireland in the thirdlevel student population. Third-level institutions in Cork have an opportunity to encourage and improve
awareness of students about STIs and the available resources, such as through increased availability of
sexual health workshops.
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ABSTRACT
This paper aimed to research the Human Papilloma Virus (HPV) vaccine uptake which prevents cervical
cancer (caused by HPV), and an evaluation of the Cervical Check system in Ireland for cervical cancer
detection. Topics discussed were the preventative and detection measures for cervical cancer in Ireland.
The population studied was 18–25-year-old women in Ireland. This study was conducted online,
through Google forms, Facebook and the UCC surveys portal. The survey was anonymised, and the
participants agreed for their data to be used for publishing in a scientific peer-reviewed research paper.
A total of 776 participants were analysed using excel spreadsheets and data collation methods like
histograms. In our study it was determined that 53.6% of young women in Ireland mistrust the Irish
Cervical Check system in Ireland. It was found that a source of this mistrust was the lack of education
and bias in news headlines surrounding the HPV cervical cancer preventative vaccine and the scandal
in 2011. A total of 63.5% of our survey population did not receive the HPV vaccine because of parental
influence and 79.8% of our participants would get the vaccine again in comparison to 89% who received
it originally (9.2% decline in uptake). In conclusion, more education is needed to avoid poor uptake of
the HPV vaccine and promote compliance with cervical smear testing in Ireland in the future to decrease
the prevalence of cervical cancer in the general population..

KEYWORDS: Cervical cancer, HPV, vaccinations.

INTRODUCTION
Cervical cancer is a cancer of the cervix, and it occurs when pre-cancerous cells mutate and grow at an
uncontrolled rate to form tumours (Dasari et al., 2015). The presence of abnormal cells in the cervix is
sometimes caused by infection with Human Papilloma Virus (HPV) (Dasari et al.,2015). According to
the 2020 annual report from the Irish Cancer Registry, 302 women in Ireland had cancer of the cervix
(National Cancer Registry Ireland, 2020). Seven out of ten cervical cancer cases are caused by strains
16 and 18 of the Human Papillomavirus (Health Service Executive, 2019a). Since 2010, young females
in the first year of secondary school have been offered the HPV vaccine and since September 2019,
young males, in first year of secondary school have also been offered the vaccine (Health Service
Executive,2021). The most common vaccine used in Ireland is the Gardasil-9 vaccine. (Health Service
Executive, 2021). Gardasil-9 protects against the nine types of HPV that cause genital warts, certain
precancerous conditions, and cancers of the cervix, vagina, vulva, anus, and head and neck, including
the oropharynx (National Cancer Institute, 2021). This vaccine is approved for use in females and males
aged 9 to 45 years (National Cancer Institute, 2021). This vaccine has greatly reduced the cases of pre-

cancers of the cervix and is attributed with a decreasing prevalence of HPV in Ireland over the past
decade (Bonanni, P et al 2015).
There are over one-hundred strains of HPV with both high and low-risk types (Braaten and Laufer,
2008). Two methods are currently used by healthcare practitioners in Ireland for the detection of
cervical cancer/HPV, which both involve the extraction of cells from the lining of the cervix for the
testing of cervical cancer. In the past, pap smears for the detection of cervical cancer cells were the
original method. Since March 2020, the gold-standard method for detection has become pap smears for
the identification of the HPV itself, rather than cancer cells. Blood testing options have seen some
promising findings for detecting HPV although it is less accurate than cervical smears, however, more
research is needed into the efficacy of these methods.
Since 2010 there has been controversy about the vaccine and the subsequent preventative measures
offered to young women to monitor the development of cervical cancer (i.e. Pap smears). The source
of this discourse was postulated to be routed in the false claims on social media that the HPV vaccine,
could cause POTS (Postural Orthostatic Tachycardia Syndrome) and CRPS (complex regional pain
syndrome), however, the European Medicines Agency in 2015 found no evidence that the HPV vaccine
causes any of the above (Yih et al., 2018). In 2010, there was a scandal involving a patient who was
presented with a false negative test and was not informed of this until three years later. Further to this,
she was diagnosed with terminal cervical cancer, it was then discovered that 161 other women received
the same false negative result and 17 have died as a result (Carswell S, 2018).
This research project aimed to investigate the level of distrust in the Cervical Check system in Ireland,
because of this scandal and learn more about the rumours and perceptions associated with the HPV
vaccine according to women in Ireland aged 18-25.

MATERIALS & METHODS
Survey population
Irish females, aged 18-25 years, were surveyed to establish their perceptions of the current measures in
place to prevent cervical cancer in Ireland.
Survey Design
The survey contained 23 questions on Google Forms. It was optional to choose multiple answers and
skip a question entirely. Close-ended and open-ended questions were used. Several questions included
the use of Likert scale to ascertain each participant’s level of agreement or disagreement with a
particular statement.
Survey distribution
The survey was distributed via Facebook and Instagram, and the UCC Surveys distribution service via
email. UCC societies pages such as UCC Cancer Society, also shared the survey with followers via
their social media pages. The survey was released on 06/03/2021 and was closed on 19/04/2021.
Data Analysis
Data were presented using Microsoft Excel, Microsoft Word, and the questionnaire platform Google
Forms. The results were interpreted using graphs and tables. Invalid responses were excluded. Only
participants born as female between the ages of 18-25 years were part of the data analysis. Closedended questions were analysed using bar charts and pie charts. Open-ended questions were divided into
categories or counted to determine the consensus.

Ethics
The survey was voluntary and anonymised, the participants agreed for their data to be published in a
scientific peer-reviewed research paper. Ethical approval and consent to use data collected, was
obtained before conducting this research study. An information sheet about the objectives of the
research was provided. All data obtained was confidential and stored in password-protected computers
and will be destroyed after 5 years. Personal identifiers or IP addresses were not collected.

RESULTS
Survey population
In total, there were 921 submissions. Of these responses, 776 were valid. Of the valid responses, 95%
(n=741) were Irish citizens and 5% (n=35) were not. A total of 99% (n=768) of these valid responses
were cis-woman, 0.5% (n=4) were non-binary assigned female at birth and 0.5% (n=4) were
transgender-men.
Regarding age, 38% (n=298) of the population were aged between 18-20 years, 53% (n=407) of the
population was aged 21-23 years and the remaining 9% were 24-25-year-olds (n=71). Invalid
respondents comprised of males and respondents 26 years of age and older. Of the population largely
came from those with a scientific background with 52% of participants having studied a science or
medical-based course.
Vaccination uptake and analysis
A total of 99% (n=767) of the population were pro-vaccination and 1% (n=9) were anti-vaccination.
However, only 89% (n=694) of the population received the Human Papilloma Virus (HPV) vaccine and
11% (n=82) did not receive the HPV vaccine. The respondents who did not receive the HPV vaccine
(n=86) were given possible reasons as to why they decided not be vaccinated (Figure 1). It can be
observed that parental influence played the biggest role (63.5%) in their choice to receive the vaccine,
followed by a lack of education (16.9%), and media influence (8.5%). Medical reasons played a minimal
role in their decision (0.9%). A total of 5.9% attributed not getting the vaccine to a negative association
with vaccines. GP influence and cost were minimal influences ranging from 1.8% to 2.5% of
participants reasoning (Figure 1).
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Figure 1: Analysis of the reasons that participants didn’t receive the HPV vaccine.

From the full population, 79.8% of participants were very likely and only 1.5% were very unlikely to
receive the vaccine if offered again for the first time, as seen in Figure 2. A total of 89% received the
vaccine in our population, however only 79.8% would get it again.

Very unlikely

1.5%

Likelihood

Unlikely

2.3%

Unsure

5.4%

Likely

11.0%

Very likely

78.8%
0.0%

10.0%

20.0%

30.0%

40.0%

50.0%

60.0%

70.0%

80.0%

90.0%

Percentage of participants (%)

Figure 2: Analysis of percentage population (n=776) that would receive the HPV vaccine if offered again
for the first time.

Analysis of side effects caused by immunisation
The participants were asked if they either a) experienced side effects themselves or b) heard of people
who suffered side effects from the vaccine and if yes (n=216), and to further specify these side effects
from a selection of options. As can be seen in Figure 3, general side effects of vaccines like
fainting/dizziness/high temperature/nausea and bruising accounted for 59.7%, then narcolepsy 16.2%,
Postural Orthostatic Tachycardia Syndrome 4.2%, paralysis 3.2% and fatigue 2.8%. A further 13.9% of
people listed other side effects through an open-ended answer box, but these were rare and hence were
accounted as ‘others’ on the graph.
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Figure 3: Side effects of the HPV vaccine that were experienced or heard about by the participants
(n=216).

General Knowledge of the Population on Cervical Cancer and the HPV Vaccine
A total of 56% (n=437) of the population do not trust the Cervical Check system used in Ireland.
When receiving the vaccine, a total of 28% of people said that they received no information about the
HPV vaccine, 65% said they received a pamphlet or letter and 11% said they received an informative
talk. When asked if participants knew how HPV was contracted to the best of their knowledge, 70%
(n=542) of people knew that HPV was transmitted sexually, 12% (n=94) said travel, skin-to-skin contact
or developing it spontaneously, and 18% (n=140) of people said they didn’t know. A total of 72%
(n=556) did not know that 70% of people will contract HPV in their lifetime. A total of 14.2 % (n=111)
did not realise that even when vaccinated against HPV, women are still required to get cervical smears.
The participants were asked whether they knew that, in combination or separately, smoking and taking
oral contraceptives increase cervical cancer risk. The survey found that 51% were aware of this.
Other findings
A total of 57.3% of participants said they would be very likely to get the vaccine if boys were also
offered it, 28.6% were unsure and the remaining 14.1% said it would have no impact on their
decision. When asked about the cost of HPV vaccination in universities, a total of 99% of students in
our survey (n= 768) said that the vaccination programme currently available is unfeasible for students
and 50.1% of students said reasonable prices should range from €50-199.
When the participants were asked if, when they turn twenty-five, they would avail of the Cervical Check
system, 77% of participants (n=597) said they would be very likely to avail of this service, whereas
23% said they would not or were not sure whether they would avail of it. The participants were then
further questioned and asked why they would not avail of this service. Of the participants, 59.7%
answered fear, 46% do not know how to organise the appointment, followed by 42.1% are embarrassed
and do not know what it involves.
When information relating to the poor sensitivity of the blood test method when compared to the pap
smear was presented to participants, a total of 16% said they would prefer a blood test. However, 73.5%
said they would use the cervical smear method (Figure 4).
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Figure 4: Preference of population for the method employed for cervical cancer screen- either vaginal
smear method or blood testing.

DISCUSSION
This research project was aimed to gain insight into the perceptions of young women regarding the
HPV vaccination programme and Cervical Check system in Ireland. The main measures used to prevent
cervical cancer, are the HPV vaccine programme and cervical smears. Cervical Check is the national
cervical cancer screening programme in Ireland.
Most cervical cancers (70%) are caused by the contraction of HPV strains 16 and 18 (Health Service
Executive, 2019a). However, once HPV is contracted it can take up to 20 years to present itself as an
infection (HPV infection - Side effects and causes, 2021). The virus can linger in the body for years,
however it will more than likely lead to the development of antibodies against the virus which will clear
it within 1-2 years (World Health Organisation, 2017). Hence, asymptomatic patients may never know
that they were infected by HPV (Connor, 2018). More than 70% of people will contract HPV in their
lifetime (Cervical Check, 2021). This was presented to the participants in the survey, and it was
determined that 71.7% were unaware of this fact. These findings highlight how uneducated people are
about HPV and highlighted the need for more education. The HPV vaccine also has strong protection
against condylomas and some HPV-related cancers. However, the HPV vaccine does not give complete
protection against cervical cancer, it can only help prevent infection (Cheng, Wang and Du, 2020)
and 14.2% of the respondents (n=776) were unaware that regular screening is still required, even if
vaccinated. From the ages of 25-60, HPV screening is completed every five years (Health Service
Executive, 2019b). Screening may need to be carried out more regularly if high-risk types of human
papillomavirus were detected such as HPV 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59 and 68 (The
British Society for Colposcopy and Cervical Pathology, 2020).
To prevent cervical cancer a nationwide vaccination programme is in place for secondary school
students. The most common vaccine in Ireland is called Gardasil-9, and it protects against the strains of
HPV that cause 90% of cervical cancers (Health Service Executive, 2021). It was determined that 99%
of respondents were pro-vaccination and 1% were anti-vaccination. When the participants were asked
if they had received the HPV vaccine in secondary school, it was deduced that 89% had received the
vaccine while 11% had not. These results were surprising and unexpected as most of the participants
were pro-vaccination. It was noted that when the participants were asked if they would have received
the HPV vaccine again, if it was being offered for the first time, only 79.8% said they would, compared

to 89% of people who received the vaccine in the first place (Figure 2). This disparity warrants further
investigation.
The participants that did not receive the vaccine (11%), were asked what influenced their choice (Figure
1). It was determined that the dominant reason was parents' influence (63.5%). This was of course,
expected, as first-year secondary school students are under eighteen and therefore require guardian
approval before getting any vaccine. Media influence was 8.5% and it should be noted that, at the time,
participants would have been receiving the vaccine (2009-2016), a large amount of misinformation was
being presented to the public through the media regarding the HPV vaccine (Yih et al., 2018). It was
also deduced that 2.5% did not receive the vaccine due to their general practitioners (GPs) influence.
GPs should present the relevant facts to the patient and guardians in order for them to make an educated
decision. A small number of respondents (0.9%) did not receive the vaccine due to medical reasons.
All vaccinations pose a risk of mild side effects, including fainting and dizziness (Centre for Disease
Control and Prevention, 2021). More than 1 in 10 people who receive the Gardasil vaccine will
experience such side effects (National Health Service, 2019a). All international bodies have continually
reported that the Gardasil vaccine causes no long-term side effects (Yih et al., 2018). The short-term
side effects of the vaccine include general mild side effects and in rare cases a severe allergic reaction
(Shah et al., 2019). False claims have led to a negative perception of the vaccine with many believing
that Postural Orthostatic Tachycardia Syndrome (POTS), and Complex Regional Pain Syndrome
(CRPS) were side effects of the vaccine (Yih et al., 2018). However, the European Medicine Agency
(EMA) declared that there was no evidence of this being caused directly by the vaccine and the
prevalence of these symptoms didn’t deviate from the expected occurrences of these symptoms in the
population, without the vaccine (EMA, 2015).
It was determined from Figure 3, that the participants also experienced or heard of someone
experiencing side effects like narcolepsy (16.2%), POTS (4.2%), paralysis (3.2%), dizziness (59.7%)
and a further 13.9% answered ‘other’ and cited side effects such as insomnia and seizures. The
representation of these side effects was not large enough to be accounted for in the graphical results. It
was reported in 2010-2015, 958 out of 590,694 girls (0.2%) experienced a negative reaction from the
HPV vaccine (MagGuill, 2017).
The HPV vaccination programme is free and offered to first-year students in secondary school (Health
Service Executive, 2021). Young females, since 2010, and males since 2019, can receive the HPV
vaccination (Corcoran et al., 2021). Since September 2020, boys in secondary school have been offered
the vaccine. A total of 57.3% of participants said they would be very likely to get the vaccine for this
reason, 28.6% were unsure and the remaining 14.1% said it would have no impact on their decision (ie.
a score of 0 on the Likert scale). This highlights that most women would be more likely to get the
vaccine, due to this change in the vaccination programme protocol. It is not to be forgotten that HPV
can cause anal-genital warts in males (Royal College of Physicians Ireland, 2018). Herd immunity is
dependent on high levels of vaccination uptake in both males and females, not just females alone (Royal
College of Physicians Ireland, 2018).
There are two vaccines developed to prevent HPV 16/18 related cancers (Clendinen C et al., 2016). The
quadrivalent HPV recombinant vaccine called Gardasil-9 and the bivalent HPV vaccine called Cervarix
were developed by Merck and GlaxoSmithKline (GSK, 2019). The cost for three doses of the HPV
vaccine in University College Cork student medical centre is €555 (University College Cork, 2018). A
student might avail of this if they did not get the vaccine for free in secondary school. The cost in
University College Dublin is €685.50 (University College Dublin, 2021). A total of 99% of students in
our survey say the cost of the vaccination programme make it unfeasible for students and 50.1% of
students said reasonable prices should range from €50-199. In other European countries, the timeframe
in which the vaccine can be received for free is much wider, for example in Germany the vaccine is
given free of charge to females between the ages of 12-17 years and, in addition to this, some statutory
health insurance providers cover the complete cost of the vaccine in females aged 18-26 years old
(Hense et al., 2014).

The participant’s knowledge was assessed on HPV, the vaccine and cervical cancer. When asked what
information participants received in secondary school, 28% of people said they received no information
about the HPV vaccine and this may provide possible reasons why there was a poor uptake of the
vaccine. Most participants (65%) said they received a pamphlet with information, and 11% said they
attended an informative talk. These findings prove that people didn’t receive enough information about
the vaccine.
Most of the participants, 70%, knew that HPV was transmitted sexually, 12% gave answers like travel
and skin-to-skin, and 18% of people said they did not know that HPV is transmitted sexually.
Smoking and the oral contraceptive pill increase the risk of cervical cancer (Ryan et al., 2018). It was
deduced from the general knowledge of the population on cervical cancer and the HPV vaccine that
49% were unaware of this. This emphasises that the population are not aware of the carcinogenic effects
of the pill and smoking and need better health promotion and awareness.
This is an area that encourages a lot more investment for non-profit organisations and more government
funding. Possibly, if when young females are offered the HPV vaccine in secondary school for free,
and if they were informed of the price of the vaccine later, this may result in higher vaccine uptake.
However, public perception of the price of vaccines is misinformed, it may be forgotten the cost of
regulating these vaccines, distributing them and low market prices leave the production companies with
little to no profit as they are expensive (Xue et al., 2020).
In January 2019, around 21,000 people underwent a cervical smear test; in January 2020 that number
had fallen to 17,000 and further to this, in March 2021, 29,000 women were attending for cervical
screening, which is an increase when compared to previous months (Cervical Check, 2020). Participants
were surveyed about cervical smear uptake and education around the topic of the cervical check system
in Ireland and the perception of the system itself. Of note, 53.6% of people do not trust the cervical
check system in Ireland and would not trust their result since the scandal in 2019. Women can avail of
Cervical Check when they are 25 years old, 77% of participants (n=597) said they would be very likely
to avail of this service, whereas 23% said they wouldn’t or weren’t sure whether they would avail of it.
The participants were then further questioned and asked why they would not avail of this service. Of
the participants 59.7% answered fear, 46% don’t know how to organise the appointment, followed by
42.1% who are embarrassed and don’t know what it involves. The participants could select more than
one option in this case.
Many participants were concerned that the minimum age of screening for cervical cancer is 25 and they
wished for it to be lower. However, population-based screening in women under the age of 25 may lead
to many women receiving unnecessary treatment for lesions that would never have developed into
invasive cancer and early screening might also lead to unnecessary anxiety and upset (Cervical Check,
2021). Premature screening can cause potential risks with some treatments, including a slightly
increased risk of early birth if the patient was pregnant. (Cervical Check, 2021).
The participants were asked if they would prefer another form of detection of cervical cancer that did
not involve the smear test such as a blood test and they were informed that it would have decreased
sensitivity compared to the cervical smear sensitivity. A total of 16% said they would prefer a blood
test despite sensitivity differences (Figure 4). Further investigation into the clinical utility of blood tests
is necessary and it may provide evidence that it could be combined and used as an adjunct test, with the
traditional cervical smear for optimal patient outcomes. This method would provide a less intrusive and
more convenient for the patient (Boltz, 2021).
As the study was distributed through the UCC Survey platform, mostly college-educated students
answered the survey and approximately 52% of our population studied some form of science or
medicine course. This may have led to an increased amount of scientific knowledge in our population
compared to a non-scientific population surrounding HPV and cervical cancer.

In conclusion, the findings of this study suggest, education and factual scientific information on cervical
cancer, are lacking amongst young women in Ireland. Knowledge of the subject would increase
participation in the vaccination programme and increase the uptake of cervical smears. There is scope
for new, less invasive, and less daunting methodologies to increase participation of the public to be
tested for cervical cancer. In turn, this would decrease the prevalence of cervical cancer in the
population. There seems to be a need for a revision of the price of the HPV vaccination programme
after secondary school. There is discord and lack of trust between the Irish public and the Cervical
Check system in Ireland, more research should be aimed at rebuilding this trust.

ACKNOWLEDGEMENTS
The authors would like to thank Dr. Brigid Lucey and Dr. Annemarie Burns of Munster Technological
University

Corresponding author: Ruth Delahunty (delahuntyruth@gmail.com)

REFERENCES
BMC Public Health, 2018. Decline in HPV-vaccination uptake in Denmark – the association between HPVrelated
media
coverage
and
HPV-vaccination.
[Online]
Available
at:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288961/ [Accessed 17 May 2021].
Bonanni, P., Bechini, A., Donato, R., Capei, R., Sacco, C., Levi, M. and Boccalini, S., 2015. Human papilloma
virus vaccination: impact and recommendations across the world. [article] Therapeutic advances in vaccines,
3(1), pp.3-12.
Braaten, K.P. and Laufer, M.R., (2008). Human papillomavirus (HPV), HPV-related disease, and the HPV
vaccine. [article]. Reviews in obstetrics and gynecology, 1(1), p.2.
Bsccp.org.uk. 2020. Frequently Asked Questions. The British Society for Colposcopy and Cervical Pathology.
[online] Available at: <https://www.bsccp.org.uk/women/frequently-asked-questions> [Accessed 17 May 2021].
Burd, E.M., 2003. Human papillomavirus and cervical cancer. [article] Clinical microbiology reviews, 16(1),
pp.1-17.
Cdc.gov. 2021. Possible Side effects from Vaccines | CDC. [online]
<https://www.cdc.gov/vaccines/vac-gen/side-effects.htm> [Accessed 17 May 2021].

Available

at:

Cheng, L., Wang, Y. and Du, J., 2020. Human Papillomavirus Vaccines: An Updated Review. [online] NCBI.
Available at: <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565290/> [Accessed 7 November 2021].
Clendinen, C., Zhang, Y., Warburton, R.N. and Light, D.W., 2016. Manufacturing costs of HPV vaccines for
developing countries. [article]. Vaccine, 34(48), pp.5984-5989.
Connor, E., 2018. Human Papillomavirus (HPV): Does It Go Away? [Online] Available at:
https://www.healthline.com/health/sexually-transmitted-diseases/does-hpv-go-away [Accessed 10 May 2021].
Corcoran, B., Anna, C. & Barrett, T., 2021. How Ireland reversed a HPV vaccination crisis. [Online] Available
at: https://www.hpvworld.com/articles/how-ireland-reversed-a-hpv-vaccination-crisis/ [Accessed 10 May 2021].

Dasari,S., Wudayagiri, R. and Valluru, L., 2015. Cervical cancer: Biomarkers for diagnosis and treatment.
[online]
Science
Direct.
Available
at: <https://www.sciencedirect.com/science/article/abs/pii/S0009898115001370> [Accessed 6 November 2021].
Dyer, C., 2020. Irish Supreme Court upholds win for woman whose cervical cancer was missed. [online] Available
at: <https://www.bmj.com/content/368/bmj.m1196.full > [Accessed 17 May 2021].
European Medicines Agency, 2015. Review concludes evidence does not support that HPV vaccines cause CRPS
or POTS. [Online] Available at: https://www.ema.europa.eu/en/news/review-concludes-evidence-does-notsupport-hpv-vaccines-cause-crps-pots [Accessed 13 May 2021].
GlaxoSmithKline (2009). FDA approves Cervarix, GlaxoSmithKline’s cervical cancer vaccine | GSK. [online]
Available
at:
https://www.gsk.com/en-gb/media/press-releases/fda-approves-cervarix-glaxosmithkline-scervical-cancer-vaccine/ [Accessed 1 Dec. 2021].
Hense, S., Hillebrand, K., Horn, J., Mikolajczyk, R., Schulze-Rath, R. and Garbe, E. (2014). HPV vaccine uptake
after introduction of the vaccine in Germany. Human Vaccines & Immunotherapeutics, [online] 10(6), pp.1729–
1733. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5396220/ [Accessed 2 Dec. 2021].
Health Service Executive, 2019. Cervical cancer - causes. [online] Www2.hse.ie. Available at:
https://www2.hse.ie/conditions/cervical-cancer/causes.html [Accessed 17 May 2021].
Health Service Executive. 2019b. Who should have cervical screening? [online] Available at:
<https://www2.hse.ie/screening-and-vaccinations/cervical-screening/when-you-should-have-cervicalscreening/who-should-have-cervical-screening.html> [Accessed 17 May 2021].
HSE.ie.
2021
HPV
Vaccination
Programme
HSE.ie.
[online]
Available
at:
<https://www.hse.ie/eng/health/immunisation/pubinfo/schoolprog/hpv/hpv-vaccination-programme/> [Accessed
11 May 2021].
Irish Cancer Society. 2021. Cervical cancer screening. [online] Available at: <https://www.cancer.ie/cancerinformation-and-support/cancer-types/cervical-cancer/cervical-cancer-screening> [Accessed 11 May 2021].
Jewell, T., 2020. Can HPV be Dormant?. [Online] Available at: https://www.healthline.com/health/how-longcan-hpv-be-dormant [Accessed 17 May 2021].
Kathy Boltz, P., 2021. Simple blood test can indicate cervical cancer - Oncology Nurse Advisor. [online]
Oncology Nurse Advisor. Available at: <https://www.oncologynurseadvisor.com/home/headlines/webexclusives/simple-blood-test-can-indicate-cervical-cancer/> [Accessed 11 May 2021].
Kings College London., 2021. Only one in four people experience mild systemic side effects from COVID-19
vaccines. [online] Available at: <https://www.kcl.ac.uk/news/one-in-four-people-mild-side-effects-covid-19vaccines> [Accessed 17 May 2021].
Mayo Clinic., 2021. HPV infection - Symptoms and causes. [online] Available at:
<https://www.mayoclinic.org/diseases-conditions/hpv-infection/symptoms-causes/syc-20351596> [Accessed 6
November 2021].
National Cancer Institute Cervical Cancer., 2021. Human Papillomavirus (HPV) Vaccines. [online] National
Cancer Institute. Available at: <https://www.cancer.gov/about-cancer/causes-prevention/risk/infectiousagents/hpv-vaccine-fact-sheet.> [Accessed 18 May 2021].
National Cancer Institute., 2021. HPV and Cancer. [online] Available at: <https://www.cancer.gov/aboutcancer/causes-prevention/risk/infectious-agents/hpv-and-cancer> [Accessed 17 May 2021].
National Cervical Cancer Coalition., 2021. Cervical Cancer Overview. [Online] Available at: https://www.nccconline.org/hpvcervical-cancer/cervical-cancer-overview/ [Accessed 17 May 2021].

National
Health
Service,
2019.,
HPV
vaccine
side
effects.
[Online] Available
at:
https://www.nhs.uk/conditions/vaccinations/hpv-vaccine-cervarix-gardasil-side-effects/ [Accessed 10 May
2021].
Ogilvie, G.S., van Niekerk, D., Krajden, M., Smith, L.W., Cook, D., Gondara, L., Ceballos, K., Quinlan, D., Lee,
M., Martin, R.E. and Gentile, L., 2018. Effect of screening with primary cervical HPV testing vs cytology testing
on high-grade cervical intraepithelial neoplasia at 48 months: the HPV FOCAL randomized clinical trial. [article]
Journal of the American Medical Association 320(1), pp.43-52.
Royal College of Physicians of Ireland, 2018. Extending HPV vaccine to boys- Why is it so important?. [online]
Available
at:
<https://www.rcpi.ie/news/releases/extending-hpv-vaccine-to-boys-why-is-it-so-important/>
[Accessed 11 May 2021].
Ryan, M., Marlow, L. and Waller, J., 2018. Socio-demographic correlates of cervical cancer risk factor
knowledge among screening non-participants in Great Britain. [online] Science Direct. Available at:
<https://www.sciencedirect.com/science/article/pii/S0091743519301653> [Accessed 6 November 2021].
Schiller, J.T., Castellsagué, X., Villa, L.L. and Hildesheim, A., 2008. [Article] An update of prophylactic human
papillomavirus L1 virus-like particle vaccine clinical trial results. Vaccine, 26, pp.K53-K61.
Shah, P.D., Calo, W.A., Gilkey, M.B., Boynton, M.H., Dailey, S.A., Todd, K.G., Robichaud, M.O., Margolis,
M.A. and Brewer, N.T., 2019. Questions and concerns about HPV vaccine: a communication
experiment. Pediatrics, 143(2).
Suppli, C.H., Hansen, N.D., Rasmussen, M., Valentiner-Branth, P., Krause, T.G. and Mølbak, K., 2018. Decline
in HPV-vaccination uptake in Denmark–the association between HPV-related media coverage and HPVvaccination. BMC Public Health, 18(1), pp.1-8.
The Irish Times (2018) Cervical Check scandal, what is it all about, May 2018, available:
http://www.irishtimes.com/newspaper/innovation/2009/0511/1224246162408.html [accessed 15 February 2021].
University College Dublin., 2021. UCD Student Health Service | HPV Vaccine. [online] Available at:
<https://www.ucd.ie/stuhealth/services/hpvvaccine/> [Accessed 17 May 2021].
University College Cork. 2018., Charges | University College
<https://www.ucc.ie/en/studenthealth/fees/> [Accessed 17 May 2021].

Cork.

[online]

Available

at:

World Health Organisation,. 2021. Human papillomavirus (HPV) and cervical cancer. [Online] Available at:
https://www.who.int/news-room/fact-sheets/detail/human-papillomavirus-(hpv)-and-cervical-cancer [Accessed
17 May 2021].
Xue, Q.C. and Ouellette, L.L., 2020. Innovation policy and the market for vaccines. Journal of Law and the
Biosciences, 7(1), p.lsaa026.
Yih, W., Maro, J., Nguyen, M., A Baker, M., Balsbaugh, C., V Cole, D. and Dashevsky, I., 2018. Assessment of
Quadrivalent Human Papillomavirus Vaccine Safety Using the Self-Controlled Tree-Temporal Scan Statistic
Signal-Detection Method in the Sentinel System. [online] American Journal of Epidemiology. Available at:
<https://academic.oup.com/aje/article/187/6/1269/4904164?login=true> [Accessed 6 November 2021].

An Investigation into the Prevalence of Use and Availability of
Information on Contraception for Female Third Level Students
aged 18-24
Barbara Dymet*, Jane Hyde*, Chloe Madden*, Ciara Walsh*
*Department of Biological Sciences, Munster Technological University, Bishopstown, Cork, Ireland.

ABSTRACT
Introduction: The purpose of this investigation was to find out the number of female students in thirdlevel institutions who use different types of contraception as well as their opinions on contraception,
including cost and the availability and adequacy of information about female birth control options
available in second and third level institutions. For females to make an informed decision on whether
contraception should be availed of and what type of contraception should be used, education is
necessary, and this study aimed to assess the student’s knowledge of contraception and to identify if
improvements need to be made to contraception education for female students. The secondary aim of
this study was to assess the knowledge of the participants on the relationship between the use of
contraception and sexually transmitted diseases (STDs).
Materials and Methods: An online survey was created using Google Forms which was distributed to
undergraduate third level female students over the age of 18. All gathered data was analysed using
Microsoft Excel.
Results: The majority (69.6%) of the surveyed population (n=115) was sexually active and used
contraception with the most common form being a combination of the contraceptive pill and condoms.
More than half (53.05%) of the survey participants believe there is not enough information available to
them in their third level institutions while 50% of the females that do not use any form of contraception
agree that sufficient information is provided in third level institutions.
Discussion: This survey highlighted important issues such as the lack of information provided in both
post-primary and third level settings. A more open discussion about contraception should be made
available to young women, especially in colleges, as it could encourage more females to use
contraception and show that there are options, other than condoms, which are most mentioned by
colleges, but are one of the least effective forms.

KEYWORDS: Contraception, injectable contraception, birth control pill, bar, patch, condom,
abstinence, sexually transmitted infection (STI)/sexually transmitted disease (STD), intermenstrual
spotting.

INTRODUCTION
There are many forms of female contraception available including the birth control pill, the patch,
injectable contraception, intrauterine device (IUD), vaginal ring, diaphragm and the emergency
contraceptive pill. However, contraception is not only used for pregnancy prevention. Contraceptive
methods may also be used by women for a variety of reasons such as to reduce cramps or menstrual
pain, to regulate the menstrual cycle, for the treatment of acne and for the treatment of endometriosis.
Along with the benefits of contraception, a female taking contraception can also experience side effects
such as headaches, breakthrough bleeding, mood swings and weight gain. Severe and rare side effects
of contraception including blood clots can also occur. Venous thromboembolism is the most wellknown side effect associated with the pill (Liao and Dollin, 2012).
The sale of non-prescription contraceptives was approved in Ireland in February, 1985 with the pill
being fully legalised without discrimination in 1993. A survey conducted in 2014 determined that a
third of Irish women aged between 18-45 years old did not use contraception. Ireland was reported in
this study as having the fourth lowest contraception use of the 28 EU member states (O’Doherty, 2014).
When contraceptive users were asked what type of contraception they used, it was discovered that the
most common form was the pill, followed by condoms.
For females to make an informed decision on whether contraception should be availed of and what type
of contraception should be used, educational interventions are necessary. A new short course for social,
personal and health education (SPHE), with learning outcomes in the area of relationship and sexuality
education (RSE), was introduced in 2015 in Ireland as part of junior cycle developments and the new
curriculum area of wellbeing. Since 2003, the provision of the equivalent of one class period per week
(or 70 hours per annum) of SPHE is mandatory for all junior cycle students and it is required that RSE
is taught as an integral component of SPHE. In 2011, a new curriculum framework for senior cycle
SPHE was published; it is built around five areas of learning, one of which is RSE. Two reports by the
Department of Education and Skills (DES) Inspectorate focus on SPHE in primary and post-primary
schools and address issues relating to the implementation of RSE. They concluded that there were
“evident weaknesses in programme planning for senior cycle RSE in 62% of the schools inspected” and
“significant variation in the quality of provision for RSE for senior cycle students” (Keating et al.,
2018).
The primary aims of this study were to investigate the use of different types of contraception among
female undergraduate third level students and to determine their views on contraception including cost
and whether there was enough information about contraception in second level and third level
institutions for these students. The secondary aim of this study was to assess the knowledge of the
participants on the relationship between the use of contraception and sexually transmitted diseases
(STDs)

MATERIALS AND METHODS
Survey Design and Distribution
An online survey was conducted on female third level students aged 18-24 using Google Forms. An
introduction to the survey included information about the survey’s creators and its aims, informing
candidates the survey was voluntary and anonymous and that any personal data obtained will only be
retained throughout the timeframe of the survey and will be disposed of when no longer needed. The
survey was available to complete from February 19 - March 6, 2020. Email addresses of the survey
creators were also included if candidates had any queries.
The survey comprised 21 multiple choice questions divided into four main sections including
introductory questions, questions for those that use contraception, questions for those that do not use

contraception and general questions regarding contraception. Introductory questions included obtaining
the survey candidate’s consent to participate in the survey and agreeing that they were over the age of
18, as well as questions on the survey participant’s age, sexual activity, and contraception usage.
Questions for those who use contraception included what type of contraception they used and their
reason for choosing that method of contraception, if they researched the best form of contraception and
where they got the information about the best form of contraception for them, and how much they spend
on contraception each month. Questions for those who do not use contraception included what the main
reason was for choosing not to use contraception and whether they would consider using contraception
in the future. General questions regarding contraception included whether the survey candidate believed
there was enough information available about contraception in secondary school and college, if they
felt comfortable talking about contraception with friends, if they knew what forms of contraception
protect you from STDs and if they believed contraception was affordable. The survey was advertised
using the social media platforms Instagram, Snapchat and Facebook.
Survey Analysis
The results of the survey were organised into graphs and tables using Microsoft Word and Microsoft
Excel.

RESULTS
Survey Participation
A total of 115 valid responses were obtained to the survey. The survey initially targeted all female third
level students however, the demographic trend was towards a younger population with all 115 survey
respondents being third-level undergraduate students between the ages of 18-24.
This stacked bar graph ion figure 1 shows that of the 115 female undergraduate students 78.3% between
the ages 18-24 were sexually active. Of the sexually active population, 69.6% used contraception and
8.7% did not. The percentage of female undergraduate students between the ages of 18-24 that were
not sexually active was 21.7%. Of this population 9.6% used contraception and 12.1% did not. A total
of 79.1% of the survey population were contraception users.
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Figure 1: Percentage of female undergraduates aged between 18-24 who are sexually/non-sexually active
and whether they use contraception.

Reasons for Contraceptive Use
Table 1 shows the responses from the 79.1% of the surveyed population (91 out of 115) who were
contraception users and their reasons for using contraceptives. Reasons for use included pregnancy
prevention (85.7%), alleviating dysmenorrhea (30.8%), to regularise menstrual cycle (30.8%), STD
prevention (22%), to reduce acne (19.8%), managing polycystic ovary syndrome (2.2%) and to relieve
migraines (1.1%). Respondents had the liberty to select multiple reasons for using contraception.

Table 1: The frequency of 91 females aged between 18-24 years old that use contraception, and are either
sexually active, non-sexually active, or chose not to answer and the reasons why these individuals use
contraception. Respondents had the option to choose multiple reasons.
Individuals that use contraception (n=91)
Reasons to use
contraception

Frequency of
participants who are
sexually active (n=80)

Frequency of
participants who are not
sexually active (n=10)

Frequency of participants
who chose not to answer if
they are sexually active (n=1)

Pregnancy prevention

75

4

-

Alleviating dysmenorrhoea

23

5

-

Regularise menstrual cycle

24

4

1

STD prevention

20

-

-

To reduce acne

16

2

-

Management of polycystic
ovary syndrome (PCOS)

1

1

-

Migraine relief

-

1

-

The remaining 20.9% (N=24) of the survey population were non-contraception users. Reasons for
choosing not to use contraception included personal choice (41.7%), the side effects/health risks
(33.3%), previous negative experience (20.8%), same sex relationship (12.5%), lack of information
availability (8.3%), not sexually active (8.3%) and religious beliefs (4.2%). Respondents had the liberty
to select multiple reasons for not using contraception (Table 2).

Table 2: The frequency of 24 females that are aged between 18-24 years old that do not use contraception
and are sexually and non-sexually active and the reasons for why these individuals chose to not use
contraception. Respondents had the option to choose multiple reasons.
Individuals that do not use contraception (n=24)
Reasons to not
use contraception

Frequency of participants who
are sexually active (n=10)

Frequency of participants who are
not sexually active (n=14)

Personal choice

4

6

Side effects/health risks

5

3

Previous negative experience

3

2

Same sex relationship

2

1

Lack of available information

2

-

No longer sexually active

-

2

Religious beliefs

-

1

Forms of Contraceptives Used
For those participants who used contraception and are sexually active, as seen in Figure 2, 42% avail
of the pill and condom together, 26% use the pill only and 18% use condoms only. This is followed by
9% of the population using the bar, 4% using the coil and lastly 1% avail of the injection method for
contraception. For those participants who used contraception and are not sexually active, 17% use the
pill and condom together, 75% use the pill only and 8% use condom only.

Percentage of surveyed population that
use contraception

Of contraception users, 65.9% of participants researched the best form of contraception available to
them, while 34.1% did not. The most popular way of obtaining information regarding contraception
was through doctors or healthcare professionals (81.3%), followed by the internet (60.9%), friends or
family (45.3%), books/leaflets (12.5%) and the least common was college or school (6.3%).
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Figure 2: The forms of contraception used among sexually active and non-sexually active surveyed
participants.

Cost of Contraceptives

Percentage of participants who agree or
disagree

For females who were contraceptive users (n=91), 41.7% believed that contraception was affordable
and 37.4% believed it was not. For females who were non-contraceptive users (n=24), 7.8% thought it
was affordable while 13% thought it was not (figure 3).
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Figure 3: Opinions of 115 female college students on the affordability of contraception.

Availability of Information on Contraceptives
For those that use contraception, the majority (54.9%) believed not enough information about
contraception is provided in third level institutions, 36.3% found the information to be adequate and
8.8% neither agree nor disagree. Conversely, the majority of those that do not use contraception (50%)
believe enough information about contraception is provided in third level institutions, 45.8% feel there
is not enough available information and 4.2% neither agree nor disagree (figure 4A).
The majority of both those who use contraception and those who do not believe enough information is
provided about contraception in the secondary school setting (80.2% and 83.3%, respectively). For
those that use contraception only 12.1% agree that adequate information is available in secondary
education, while 6.6% neither agree nor disagree. For those that do not use contraception, 16.6% believe
sufficient information was provided in secondary schools and 4.2% neither agree nor disagree (Figure
4B).
When asked about the knowledge of the forms of contraception that protect against STDs, the vast
majority (77 out of 115) correctly answered condoms and abstinence. However, the second highest vote
(33 out of 115) was for condoms only, followed by 3 of the 115 choosing abstinence only and one vote
each for patch only, coil only, bar only, pill only and pill and condom.

Figure 4: Opinions of surveyed third level female students who use contraception (n=91) and those that
do not (n=24) regarding the information available about contraception in a) colleges and b) secondary
schools.

DISCUSSION AND CONCLUSION
The purpose of this survey was to investigate the usage and views of female undergraduate students
between the ages of 18-24 that avail of contraception. The survey also gathered information on this
population's knowledge of the type of contraception that protects against STDs. Providing
comprehensive, objective information equips female students to make educated choices regarding their
sexual health and overall wellbeing. Participants of this survey included 115 female undergraduate
students between the ages of 18-24 years old. The method of surveying involved an online anonymous
survey that was sent out via email to female third level college students and on a variety of social media
platforms. An online survey was used instead of a face-to-face survey because it was thought that survey
participants would be more willing to divulge personal information regarding their sexual activity and
use of contraception through an online forum. This survey strategy is corroborated by Duffy et al.
(2005) who concluded that face-to-face respondents were more susceptible to social desirability bias
due to the presence of an interviewer.
To establish the prevalence of use of contraception, survey participants were asked if they used
contraception and if they were sexually active. As seen in Figure 1, most of the participants were

sexually active and use contraception. Interestingly this was followed by those who were not sexually
active but use contraception, pointing to the variety of reasons for the of use contraception. Of the
participants that were not sexually active, the majority did not use contraception. These results signify
that there are third level female students that do not protect themselves from sexually transmitted
diseases (STDs) or unplanned pregnancies.
For those participants who use contraception and are sexually active, as seen in Figure 2, the most
popular form of contraception was the pill and condom (42%). Use of both the pill and condoms is a
good option since barrier methods of birth control, such as the condom or diaphragm, have been proven
to be less effective at preventing pregnancy when used as the sole form of contraception (Colquitt and
Martin, 2017). With typical use, condoms are 82% effective and protect against sexually transmitted
infections, which hormonal contraception does not provide. However, 40% of sexually active survey
participants do not use a barrier form of contraception which leaves them susceptible to contracting
sexually transmitted infections. This result could mean that these sexually active participants are not
educated on the benefit of condoms for preventing sexually transmitted infections.
For non-sexually active survey participants who use contraception, the pill was the most used form of
contraception (75%), followed by using pill and condom together (17%) and condom only (8%). A
possible explanation for non-sexually active survey participants using condoms as a form of
contraception could be that they were sexually active in the past but are no longer sexually active and
used condoms in the past when sexually active. Another explanation for these results could be that these
survey participants did not fully understand the survey question.
The incidence of use of all other contraceptive forms is very low with only about 14% of the females
that use birth control using forms such as the bar or coil. These types of contraceptives, known as longactive reversible contraceptive (LARC) methods, were found to be more than 99% effective at
preventing pregnancy (Winner et al., 2012). These findings correspond to a similar study conducted in
the United States on contraception use conducted by Huber and Ersek (2009) which found that the most
common form of contraception used by female university students was oral contraceptives and male
condoms.. The combined use of the contraceptive pill and condom has increased substantially since
then among survey participants in this study. out study concurs with a recent study that identified
unmarried women of child bearing age (15-49 years old) relied more heavily on short term acting
contraceptives such as the pill and condom rather than long acting methods such as IUD or sterilisation
(Nations, 2019).
Pregnancy prevention (85.7%) appeared to be the most prevalent reason for contraceptive use, followed
by easing of period cramps (30.8%) and regularising the menstrual cycle (30.8%). Under the other
category, participants included migraine prevention and polycystic ovary syndrome as reasons for
contraception use. This highlights the multiple additional reasons, not based on sexual activity, for using
contraception. In contrast, when non-contraception users were asked their reasons for choosing not to
use contraception, the individual’s personal choice (41.7%) was the leading reason. Many also choose
not to use contraception due to the side effects or health risks (33.3%), previous negative experience
(20.8%), same sex relationship (12.5%), not sexually active (8.3%) and religious beliefs (4.2%). It was
determined that 8.3% of candidates choose not to use contraception due to the lack of knowledge
available to them.
Figure 3 depicts the views of the participants on the perceived affordability of contraception. For those
that use contraception, 41.7% thought contraception was affordable and 37.4% thought it was not. For
participants who do not use contraception, 7.8% thought it was affordable and 13% thought it was not.
This is an interesting outcome since those who actually use contraception do not think that it costs too
much. This could be a misconception of non-contraceptive users that may be a result of the lack of
reliable information. However, an Irish survey conducted by the Central Statistics Office in 2010 found
that 18% of respondents had an issue with contraception cost. The impact of contraception costs can be
seen in a Spanish study investigating the use of oral contraceptives by women between the ages of 1530. This study revealed a decrease in the use of the pill from 14.4% in 2006 to 10.2% in 2012 (Carrasco-

Garrido et al., 2016). One of the major contributing factors to this reduction observed by the authors
was the economic recession, highlighting that the cost of contraception can impact its prevalence in a
population. It is important to note that due to a recent recommendation of the Report of the Joint
Committee on the Eighth Amendment of the Constitution, free contraception will be made available for
women aged 17-25 from August 2022.
Survey candidates were also asked about their views on the availability of information about
contraception in third level institutions and secondary schools. In Figure 4, 54.9% of candidates who
use contraception believe not enough information in third level institutions about contraception is
available to them. However, interestingly, half of those who do not use contraception agree there is an
adequate amount of information provided to students in college about female contraception. An
overwhelming majority of both populations think there was not enough information given to them about
contraception in secondary school with 80.2% of contraception users and 83.3% of non-contraception
users having this opinion. In a study by Young et al. (2018), it was determined that 25.7% of Irish boys
and 21.2% of girls between the age of 15–18 years were sexually initiated. These findings highlight the
need for education and the availability of information about contraception in secondary schools. A
survey carried out in Brazil, concluded that the knowledge of contraceptive methods was low in both
private and public school students (Martins et al., 2006). These findings highlight the need for education
and the availability of information about contraception in secondary schools.
The 115 survey candidates were also tested on their knowledge of contraception in the survey.
Participants were asked to choose which form of contraception protected them from sexually
transmitted diseases (STDs). Although the majority chose the correct answer, four participants that
answered this question thought incorrectly that pill, bar, patch, or coil usage could prevent STDs,. Only
condoms or abstinence can effectively protect against STDs. This demonstrated a lack of knowledge
around the use of contraception and could explain why some of the 40% of sexually active survey
participants in Figure 2, are not using a barrier form of contraception. In a 2014 survey it was determined
that young adults (20-29 years) represented 59.1% of STI notifications in Ireland in 2012. The
population surveyed were 56.1% female and 78.1% undergraduates and the survey concluded that
young people do not always have the information to take responsibility for their sexual health (Lally et
al., 2015).
Based on the results of this snapshot survey a higher response rate from non-contraceptive users would
have provided more accurate results in relation to whether enough information is available in college
for female students. Also, survey candidates who do not use contraception could have been given the
answer option of contraception being unaffordable for the reason they do not use contraception. This
additional question could establish if the affordability of contraception was a deterrent for some of the
20.8% of survey participants who do not use contraception. Another possible reason for survey
candidates thinking that contraception was not affordable could be due to lack of information available
to them. The last part of the questionnaire was a feedback section. The respondents believed the survey
highlighted important issues such as lack of information provided in both post-primary and third level
settings and that a more open discussion about contraception should be made available to students and
young women.
In conclusion, the main findings of this study were that female undergraduate students aged between
18-24 believe there is not enough information about contraception available to them in secondary
schools and third level institutions. This was supported by the findings that colleges and schools were
the least popular sources of information on contraception and some survey candidates did not use
contraception because there is not enough information available to them. This resulted in some
participants not knowing what forms of contraception protected them from STDs and could be the
reason why some of the 40% of sexually active survey participants do not use a barrier form of
contraception. Two thirds of female students that currently do not use contraceptives would be willing
to start using contraception in the future. Therefore, recommendations could be made to secondary
schools and third level institutions to improve the information they give their students about
contraception in order to support female student wellbeing and compensate for these deficiencies. Such

recommendations could include enacting more relevant public health initiatives especially during
sexual health awareness and guidance week.
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ABSTRACT
Codeine phosphate is a mild to moderate analgesic and has a weak cough suppressant activity that is
available to purchase as an over the counter (OTC) painkiller in Ireland as a compound product. In
recent years, countries such as Australia have introduced laws that prohibit the sale of the drug without
a valid prescription. The primary aims of the study were to determine knowledge among the public of
codeine-containing medications and their usage levels. The survey also investigated whether current
regulations and recommendations are being followed in Ireland. The survey was distributed to 543 Irish
adults using an online platform in February 2020. Only 47.2% (n=256) of those surveyed were able to
correctly identify a codeine-containing medicine from a list provided.
Analysis of the results obtained from the study revealed that only 8.6% of the surveyed population were
unaware of the potentially addictive nature of the drug. Consumers were more likely to be questioned
and sold an over the counter (OTC) codeine-containing medicine under the supervision of a member of
pharmacy staff rather than the pharmacist (73%) which is not compliant with Irish Law. This may pose
a potential danger to patient safety. An examination of the population’s opinion on whether the drug
should remain an OTC medicine or introduce changes in regulation that would make the drug a
prescription-only item showed that 47% of those asked believed that the medicine should remain OTC,
while 53% would be of the opposing opinion.

INTRODUCTION
Codeine phosphate is a mild to moderate analgesic and has a weak cough suppressant activity that is
often sold in conjunction with other over-the-counter analgesics. The Pharmaceutical Society of Ireland
(PSI) currently recognises codeine as a schedule 5 controlled drug; as such it may be purchased in a
pharmacy without a prescription under the supervision of a pharmacist (PSI, 2019). Compound codeine
products can currently be purchased over the counter (OTC) in 12 of the 27 EU states and also within
the United Kingdom. A compound codeine product contains the drug codeine, as codeine phosphate, as
an active pharmaceutical agent but may also contain one or more other active ingredients such as
paracetamol or ibuprofen.
Unlike pain medications such as paracetamol which block the release of prostaglandins to reduce pain
and inflammation (Graham, 2005), 5-10% of codeine phosphate is converted to morphine when
consumed. The morphine binds to mu-opioid receptors in the brain preventing the recognition of pain
signals (Bhandari, 2011) giving the ‘high’ or sedative qualities sometimes associated with codeine
consumption however, equally this is the reason the drug is subject to being abused.
Codeine has been demonstrated to be a highly abused substance in countries such as the United States
contributing to the so-called ‘opioid crisis’ (Kahan, 2011). Abuse of the drug has resulted in some
countries such as Australia taking legal measures to ensure that the drug cannot be misused due to ease

of access (TGA, 2020). From February 2018, medicines that contain codeine can no longer be purchased
over the counter in pharmacies in Australia and a prescription is necessary.
The purpose of the current research was to gain an insight of the knowledge individuals have on
codeine-containing medicines, where individuals source the medication and the procedure involved in
sourcing a codeine product. It is hoped that this research will begin further research into codeine
medicines in Ireland and the associated regulations.

MATERIALS & METHODS:
Survey Design
People of varying ages and who reside in the Republic of Ireland for at least 10 months of the year were
surveyed using a survey entitled “A snapshot investigation into the availability and access to codeinecontaining medications amongst the Irish Population.” An anonymous survey comprising 19 questions
was created using Google Forms where applicable, it was optional to choose multiple answers or skip
the entire question. Questions were included to gather relevant information such as participant
demographics, usage and acquisition of codeine-containing medications and knowledge of codeine
products. Opinions on the supply of codeine were also welcomed.
Distribution of the survey
The main method used to distribute the survey was online via social media platforms, namely Facebook,
WhatsApp and Instagram. It was also circulated via email among the UCC student body using the
service surveys@umail.ucc.ie. WhatsApp and Facebook were mainly used to reach the older population
(>51 years). This was important to reduce bias and the likelihood of an invalid response. The survey
was open for responses from the 18th February 2020 until the 9th March 2020..
Inclusion and exclusion criteria
For a response to be included in the data, the respondent had to be able to identify any codeinecontaining product in Question 16 of the survey. If the respondent selected a non-codeine-containing
medication, they were excluded from the data analysis. If a respondent identified a non-codeinecontaining product as a codeine-containing product it was determined that they may not have a
comprehensive understanding of the drug.
Data analysis
Data analysis was conducted us Microsoft EXCEL which allowed the responses to be organized based
on age, gender and uses of codeine. Chi square testing was used to test the statistical significance of any
novel findings, using the formula:

RESULTS
The survey yielded a total of 543 responses. These responses yielded 256 responses from individuals
who could correctly identify codeine-containing products from a provided list, 63% of whom were aged
18-28y; 10% were aged 29-39y; 9% were aged 40-50y; 18% were 50y or older. There were two
inclusion criteria which had to be met for the individual’s response to be considered for data analysis 1) the respondent had to be able to identify at least one codeine containing drug from the list provided,
and 2) the respondent did not incorrectly identify a non-codeine-containing product as a codeinecontaining product. These criteria were put in place to ensure that respondents had a suitable knowledge
of codeine containing products, which may influence their responses. The responses of these individuals
formed the basis of the results below. Figure 1 shows the means of procurement of codeine by age and
Figure 2 outlines the approach used by age of those who entered a pharmacy without a prescription.

Figure 1: Influence of age on the means of procurement of codeine containing medications.

Figure 2: Analysis of the influence of age on the purchasing protocol for individuals whose primary
means of sourcing codeine is from a pharmacy without a prescription.

Chi square statistical analysis of the apparent finding that men are twice as likely not to be asked
questions prior to purchasing Codeine-containing medications compared with women [Figure 3], found
that at a 0.1 confidence interval that the result was not significant: with a p-value of 0.1522. This
suggests that the finding may be an artifact of the disparity between the number of male and female
participants.

Figure 3: Analysis of the influence of gender on the purchasing protocol of codeine containing products.

Figure 4 shows the results of investigating the propensity to lie in order to acquire codeine, sorted by
age-group. Figure 5 shows the survey population’s opinion on whether codeine acquisition should need
a prescription, by age-group.

Figure 4: Analysis of the influence of age on an individuals’ willingness to lie to a healthcare professional
in order to obtain codeine. Each bar represents the percentage of individuals in that age cohort who admitted to
lying to obtain a codeine counting product.

Figure 5: Analysis of 256 Irish individuals’ opinions as to whether or not codeine should be prescription
only, by age group.

Figure 6: Justification of 121 Irish survey respondents who believe codeine should remain an over-thecounter drug.

Figure 6 is concerned with the respondent’s (n=121) reasons for retaining codeine containing
medications as over the counter products. The most common reason for this was the cost associated
with visiting a doctor to obtain a prescription (34%), followed by the belief current regulation of codeine
was sufficient (20%). Other reasons given were: individuals should know to use codeine containing
medications responsibly, requiring a prescription to obtain codeine containing medications would cause
an added strain on the healthcare system and some individuals believed it should be freely available
after answering a series of questions in relation to the purchase of the medication.

Figure 7 demonstrates the respondent’s (n=135) reasons for codeine containing medications being
available on prescription only. Under the category “Other” reasons supplied were that the drug is abused
and misused and that supervision of the drug is required.

Figure 7: Justifications of 135 Irish respondents who believe that codeine should be available by
prescription only.

DISCUSSION
Codeine phosphate is a mild to moderate analgesic available to purchase over the counter (OTC) in
Ireland and is often used to treat more serious types of pain that cannot be suppressed using other OTC
medications such as paracetamol or ibuprofen. Codeine has been the most consumed opiate in the world
in terms of countries in which it is consumed (International Narcotics Board, 2012).
Under Irish law, codeine is classified as schedule 5 under the Controlled Drug Regulations meaning
that it is available to patients OTC in pharmacies under the supervision of a pharmacist who should
make the patient aware of the side effects, especially of the sedating nature of the drug and emphasize
the addictive potential of the drug (PSI, 2012).
Analysis of the results obtained from the study revealed that 91.4% were aware of the potentially
addictive nature of the drug. This finding suggests that this common side-effect is well-known within
the population who can correctly identify a codeine-containing medicine. Based on these data, the
addictive nature of the drug appears to be well known.
The inability of individuals to correctly identify codeine-containing medicines was used as an exclusion
parameter for the rest of the questions, for accuracy. Current legislation in Ireland (Pharmacy Act,
2007; Regulation of Retail Pharmacy Businesses Regulations, 2008) for the supply of codeine states
that any form of advertising of codeine is strictly prohibited and it cannot be placed in the self-selection
area of a pharmacy. The inability to self-select a codeine-containing product may explain why 52.8%
of individuals incorrectly identified codeine-containing medicines.
Results illustrated in Figure 2 show that in all age brackets, consumers were more likely to be questioned
and sold an OTC codeine-containing medicine under the supervision of a member of pharmacy staff
rather than the pharmacist (73%). Over 80% of all patients aged between 40-50 were asked questions
by pharmacy staff rather than the pharmacist which is not compliant with Irish Law (Regulation of

Retail Pharmacy Businesses Regulations, 2008). More concerning, 28.5% of consumers aged 51+ were
not asked any of the necessary questions by any member of staff in the purchasing process. These
regulatory questions include who the medication is for, the type of pain experienced, the duration of
symptoms and if they are on any other medication; the purpose of asking these questions is to assess
whether the individual is suitable for codeine treatment.
Of all the population, it is this age branch who are more likely to be suffering from an underlying health
condition or taking other prescription medications which may interact with the drug and produce sideeffects. For example, antidiarrhoeal drugs such as loperamide & kaolin when taken with codeine can
result in severe constipation. Carrington Reid et al. (2015) found that chronic pain in later life is a
worldwide problem and there are many causative agents of chronic pain such as cancer, musculoskeletal
disorders such as arthritis or peripheral neuropathies.
In additional investigations into the impact of age on purchasing procedure it showed there was a clear
positive correlation between age and individuals not being asked questions was seen (R = 0.92). This
may be due to the assumption that older adults (51+) are less likely to abuse substances such as codeine;
however, the fact that individuals, particularly of this age group, are less likely to be asked questions
regarding the purpose of purchase is worrying. Whilst there is limited research into the effect codeine
is having in Ireland, a comprehensive 13-year study in Australia identified the prevalence of accidental
codeine overdoses. The data highlighted that the majority of accidental deaths were in individuals over
the age of 50 (30%) (Cairns et al., 2019).
This study found that younger respondents were found to be more likely to obtain codeine from family
and friends, with 29–39-year-olds being more than twice as likely to obtain codeine from friends than
any other group (17%). The 18–28-year-olds were also seen to obtain codeine from friends and family;
however, this was less common (7%). It is postulated that the increased number of younger people
sharing codeine medications may be associated with the lower prescription rate of codeine in individuals
<39yrs (23%), compared with individuals of 39yrs or older, who were more likely to receive the drug
on prescription (55%). A systematic review by (Beyene et al, 2014) on the subject of sharing
prescription medications demonstrated a similar result Regardless of the reasoning, the sharing of
potentially addictive drugs is suboptimal. It is also unlikely when supplying these medications that
family members/friends who supply the medication would advise of potential side-effects or the
addictive nature of codeine; and as such, may be unwittingly fuelling addiction as suggested by
Kennedy-Hendrick et al. (2016).
In an investigation of the relationship between gender and the purchasing process, illustrated in Figure
3, males were twice as likely to receive a codeine-containing medicine without any form of a
consultation process. Chi-square statistics tested determined that at a 10% confidence interval, the result
was statistically insignificant suggesting that this finding may be the result of differences in sample size
between men and women. However, as the p-value was 0.15, further study using a larger sample
population with a more even gender distribution could be used to investigate again for inequalities when
it comes to the impact of gender on the procurement of controlled substances.
Of the 15% of survey respondents willing to lie to obtain codeine (Figure 4), most of the individuals
justified their lying by stating it was easier to receive the medication this way (68%) whilst most others
said they were aware of the side effects and did not require advice (31%). The rate of lying was
particularly high in 29-39-year-old age group (22%), and it is noteworthy that Cairns et al. (2019)
recognised that 30-39 year-olds made up the second greatest proportion of unintentional codeine
overdose (28.8%).
Subsequently, the sub-population of individuals who did not use their codeine for its intended medical
purpose (herein referred to as codeine misuse) was examined. Of the 59 respondents who obtained
codeine from a pharmacy with a prescription, all used the product for its intended medicinal purpose,
with 53 of these individuals using the codeine medication for pain relief and the remainder using it for

cough relief. Similar findings were seen among individuals who obtained codeine from family and
friends.
However, when the 118 individuals who obtained codeine from a pharmacy without a prescription was
examined, 98 individuals consumed codeine for pain relief whilst 13 used the drug for cough
suppression. The remaining 9 individuals who obtained codeine from a pharmacy without a prescription
abused the drug for recreational use, euphoria, or relaxation purposes. These figures suggest that
individuals who obtain codeine for non-medicinal purposes are most likely to obtain the drug from a
pharmacy without a prescription. Of the 9 individuals who admitted to abusing codeine, four were 18–
28-year-old full-time third level students who used the drug for recreational purposes. Two individuals
were aged 40-50, and one aged 61+. Two of these participants both aged 29-39 admitted to being reliant
on codeine and agreed that codeine was widely available and easy to obtain. Perhaps the most alarming
piece of data obtained from the subset of codeine misusers, is that all the individuals described their
purchasing procedure as being asked questions by pharmacy staff rather than being referred to a
pharmacist. This finding highlights the need for stronger enforcement of regulation around codeine.
The examination of the populations' opinion on whether the drug should remain an OTC medicine or
introduce changes in regulation which would make the drug a prescription-only item the population is
closely split and those whose opinion is that it should remain OTC are differentiated by age-group in
Figure 5. The main validation for the belief that codeine should remain an OTC product (Figure 6)
included the cost associated with obtaining and renewing prescriptions (41%), followed by the idea that
current procedures and guidelines are adequate (24%) and that other pain-relieving OTC drugs are not
as effective (19%). Those who believe that regulations surrounding the drug need to be adjusted gave
the following reasons: the addictive nature of the drug (62%), maintaining patient safety (14%), and to
prevent abuse of the drug (8%)
All age categories, except one, suggested that the drug should only be available on prescription.
Notably, 72% of respondents aged 29-39y believe the drug should be available to purchase without a
prescription. Reasons for this were found to largely be associated with the added cost and wait time that
would be associated with obtaining the drug. It was also established that this age group is also the most
likely to obtain codeine from a family member or friend (8%) and represents the age group most likely
to lie to obtain codeine (22%). The suggestion by respondents that the cost of the drug would increase
with a change in regulations is a valid one. These additional charges would come from GP consultation
fees and the added pharmacy dispensing fee. The average GP visit fee in Ireland is €55-60 (Weston,
2019) and the average pharmacy dispensing fee can vary greatly dependent upon the items being
dispensed. This increase in cost would primarily affect private healthcare patients who are not enrolled
in any drug-related schemes such as the medical card (GMS) or drugs payment scheme (DPS). It was
also found that there is concern amongst the public that making codeine available on prescription only
would encourage those that are dependent on the medication to turn to illegal substance abuse due to
the additional costs associated with obtaining the drug (Shying., 2018).
A recent study published in 2019 showed that since the introduction of stricter measures on the sale of
the drug, which was enforced by the PSI through inspection, that there was a 33% decrease in the
number of codeine related overdoses in Ireland (Kennedy et al., 2019).
To conclude, the data obtained from this survey suggest that common side-effects of codeine are widely
known amongst the population. Clearly the surveyed population are mostly concerned with the
addictive nature of the drug and the impact it can have on the well-being of others as demonstrated in
figure 7. Considering the addictive nature of the drug, the low percentage (47%) of the population who
can differentiate between codeine-containing and non-codeine containing medications was concerning.
As most of the population surveyed purchased codeine over the counter, there is a need for additional
education of the population on the safe use and the dangers of codeine-containing products. Our findings
suggest a need for mandatory training to be introduced for all pharmacy staff on the protocol regarding
the sale of the drug, if only to act as a reminder of the legislation.
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ABSTRACT
The objective of this study was to evaluate college induced stress reported by college students across the
Republic of Ireland and identify the coping mechanisms used to deal with such stress. No previous studies
regarding this topic had been published in the Republic of Ireland. The authors compiled and distributed a
survey on stress throughout various Universities and Institutes of Higher Education across the Republic of
Ireland. A total of 144 third level students were surveyed between the 19th of February to the 5th of March
2020. The most common daily stress ranking among both males and females was reported to be 7 out of 10
(with 10 being the highest level of stress, and 1 the least), and the prevailing stress coping mechanisms
were: “listening to music” and “talking to others”. Most students believe stress has a negative impact on
their mental health. The results obtained demonstrated that college students experience an alarmingly high
level of stress daily, producing adverse effects on their diet, social lives, and mental health. This study
provides a basis for further research with more refined questions as the insights gained from this process
were absorbed.

KEYWORDS: College, stress, coping, mental health.

INTRODUCTION
Stress, and its impact on people, have been widely recognized in many books, journals, and articles. In
1983, a Time Magazine cover story referred to stress as the “Epidemic of the 80’s”, as if it were a disease
(Time Magazine, 1983). Survey findings and a statement from the World Health Organization classifying
stress as the “Health Epidemic of the 21st Century”, confirm the problem continues.
Stress has been defined as “the physiological experience of significant life events, trauma, and chronic
strain” (Thoits, 2010). Life transitions such as moving away from home and going to college create
opportunities for growth, change and adaptation to the individuation from one's family of origin (Hicks &
Heastie, 2008). Such college-associated transitions are considered one of the most stressful times in a
person’s life (Arnett, 2000). College students are expected to manage a more difficult workload at a faster
pace while adjusting to a new environment with minimal or no supervision (Ahead, 2007). College students
undoubtedly experience a multitude of stressors including academic issues, financial concerns, problematic
time management, and/or social strains (Showron et al., 2004). The different ways males cope with these
burdens over females is also of interest in this study. Common sources of additional pressures encountered

by females and males while studying are also issues to be reported, including students who work part-time
versus those with no jobs.
Coping is the process of spending conscious effort and energy to solve personal and interpersonal problems
(Weiten et al., 2008). In the case of stress, coping mechanisms seek to master, minimise, or tolerate stress
or stressors that occur in everyday life. A typical person will employ a mixture of many strategies when
attempting to cope with stress.
A scarcity of published research regarding stress and the utilisation and effectiveness of various coping
mechanisms among college students prompted this study. The major purpose of the study was to determine
levels of self-reported stress experienced by college students along with an investigation of other factors
that contributed to stress such as having a part-time job, together with any coping methods used by the
students to combat feelings of stress. This survey highlighted the importance of finding stress relief for
students of Higher Education across Ireland.
METHODOLOGY
Research design
The research question that was undertaken in this project involved analysing the stress experienced by
college students. This was done by conducting a web-based survey through advertising this survey via
various social media platforms. The website used for conducting the survey was ‘GoogleDocs’. The survey
consisted of both closed-ended quantitative questions and open-ended qualitative questions. The survey
was launched on the 19th of February 2020 and ran through to 5th March 2020. The survey was completed
before any mid-semester examinations took place in colleges across the Republic of Ireland.
Participants
Undergraduate university students in the Republic of Ireland participated in the study, from UCC, CIT,
NUIG, UCD and UL. A final population of N=144 was obtained. Students taking part in the survey were
made aware of the use of the data obtained and were given contact details if they encountered any issues.
Data extraction and analysis
The method of data collection used was primarily quantitative but with some open-ended qualitative data.
The survey included both open-ended and closed-ended questions. When analyzing the quantitative data,
the answers are easily comparable and statistical analysis is therefore easily conducted. Analyzing the close
ended questions required the use of data handling in Microsoft Excel to produce graphs as in the results
section. The major research questions were first analysed and the least common responses were filtered out.
By then assessing the most common responses, a treading pattern was observed and categories such as male
versus female, part time work or no part time work began to be constructed. Conclusions were drawn and
represented in charts below.
Ethics
Prior to collecting the data, informed consent was given by each participant before answering questions on
the survey. The data collected from the survey was kept anonymous, and information collected was not
discussed with anyone other than the three authors to maintain confidentiality. There was exclusion of
invalid results i.e. replicated responses or unfilled response boxes.

RESULTS
Participants Responses
In this survey, University students produced 134 valid responses (N=134) to the 25 questions asked. A total
of 144 students submitted a response to the survey however ten students who participated in the survey
submitted incomplete results or invalid answers resulting in their exclusion from the final population. Of
these respondents were n= 94 female, and n=40 were male. The proportion of females and males who had
a part time job was assessed with 24 out of the 40 males having a part time job and 72 of the 94 females
having a part time job
The Welch's T Test for unequal variances was used to assess the female and male sample’s means in relation
to one another. As the Critical P one tail value is less than 0.05, the null hypothesis is analogously rejected
which states that both samples have equal variances. The T critical value for a 95% confidence interval is
1.96. The statistic must exceed this for the null hypothesis to be rejected. Both the P and T critical one tail
figures show significant evidence to reject the null hypothesis. The alternative hypothesis proves correct,
which states that the means of the sample groups are not equal (variable).

Ranking of Self-Reported Daily Stress
All participants were asked to rank their daily stress levels on a scale from 1-10 where 10 was the highest
stress level. The average stress level reported by both genders was 7; selected by 26.5% of females and
27.5% of males. Moreover, the female population reported to be more likely than males to report a higher
level of stress with 9.5% selecting 9 on the scale, whereas 2.5% of males selected 9. Only 1.1% of the
female population chose 1 on the scale whereas 7.5% of males chose 1.
The time at which this stress is predominantly experienced by the student was further assessed. Of the
female students 50% experience stress prior to the examination period with 29.7% experiencing stress
throughout the college year and 20.21% during examination periods.
When determining the time at which stress is experienced most by the male population, 60% of males
experience stress in the timeframe prior to college examinations. 27.5% of males experience stress
throughout the college year and 12.5% during exams.

30

Number of people

25
20
15
10
5
0
1

2

3

4

5

6

7

8

9

10

Ranking of stress level ranging from 1-10
Male

Female

Figure 1: Ranking of stress levels that male and females reported on a scale of 1-10. This figure assesses the
daily stress experienced by university students. The students were broken into two categories based on gender: male
& female. They selected a level of stress on a scale of 1-10 that they reported to feel daily.

Contribution of Part Time Work to Daily Stress
The most common stress ranking reported by the male population with a part-time job was 4 whilst males
without a part-time job reported stress levels of 7. Among the females in the study no difference was
reported in the daily stress level by those with a part-time job and those without, both indicated a stress
level of 7.
The highest stress rating reported by a female with a part-time job was 9. The highest stress rating reported
by a female without a part-time job was 9. The highest stress rating reported by male with a part-time job
was 9 with the highest stress rating reported by male without a part-time job was 8.
The lowest stress rating reported by a female with a part-time job was 1 and the lowest stress rating reported
by a female without a part-time job was 2. The lowest stress rating reported by male with a part-time job
was 2 whilst the lowest stress rating reported by male without a part-time job was 1.
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Figure 2: Level of stress reported by male and female genders who work part time and who do not work part
time. All individuals selected a stress ranking (ranging from 1-10) that they believed to feel daily.

Self-Reported Stress Coping Mechanisms
Students selected coping mechanisms used for stress management to determine the most popular coping
mechanisms. Multiple answers could be selected and an option of “other” text box was provided.
The most used coping mechanisms were talking to others, music, exercise and using technology e.g., mobile
phones. The miscellaneous category reported the least common coping mechanisms and these included
food, recreational drugs, mindfulness, prescription drugs, friends, dogs, socializing and nature.
Both genders selected the same preferred coping mechanisms with 60.6% of females selecting talking to
others as their preferred coping mechanism and 58.5% choosing music. However, for males, 65% listen to
music, and 60% cope with stress by talking to others.
When determining the effectiveness of the coping mechanism used it was established that 24.4% of females
agreed their coping mechanisms were effective, 59.7% agreed that sometimes their mechanisms were
effective, and 16% agreed their coping mechanism did not work or was ineffective for them. In comparison,
just 45% of males trusted their chosen coping mechanism and 42.5% thought their coping mechanism was
only sometimes effective.
The potential impact of stress on mental health was further analysed. Of the female population 46.8%
selected ‘strongly agree’ and 42.5% selected ‘agree’ when asked if stress negatively impacts mental health.
Among the males, 30% selected ‘strongly agree’ while 45% selected ‘agree’.
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Figure 3: Reported coping mechanisms used by students. The miscellaneous categories include coping
mechanisms that were reported at a lower rate than the other categories mentioned. These coping mechanisms included
food, drugs, cooking, eating, medication, mindfulness, nature, friends, dogs, and alcohol.

DISCUSSION
The aim of this study was to determine the level of overall stress experienced by a college student, ascertain
the cause of this stress, and establish the most used coping mechanism to deal with such stress. In table 1,
the Welch's T Test for unequal variances was used to assess the female and male sample’s means in relation
to one another. The alternative hypothesis proves correct, which stated the means of the sample groups are
not equal thus the null hypothesis is rejected. Therefore, the male and female population were assessed
separately and compared against each other. The results showed that most students reported experiencing
moderate to high levels of stress daily (figure 1). There was a greater response rate by females than males,
as expected and supported by multiple studies conducted to show women are more likely to participate in
surveys than men (Curtin, 2000; Singer, 2000). College, examinations, and time management were all
contributing factors to the stress reported in the study (figure 2). Among the most used mechanisms to deal
with such stress were listening to music and talking to others (figure 3). More stress is experienced in the
period before examinations rather than throughout the college year. The Union of Students Ireland (USI)
National report on Students Mental Health in Third Level Education assessed stress, anxiety, and depression
prevalence in third level students, and their results corroborate those obtained in this study (Price. et al.,
2019).
Both males and females experience the same average daily stress, at a ranking of 7 (figure 1). Females were
found to be more likely than males to report a higher level of stress. This finding has also been reported
among the female population in a study which did not take university status into account but rather assessed
the general female population (apa.org, 2020). A psychological study carried out has shown that females
are socialised to be emotional, nonaggressive, nurturing, and obedient, whereas males are socialised to be
unemotional, aggressive, achievement oriented, and self-reliant supporting the assumption that females
experience greater emotional stress than males (May, 2017).

As average daily stress was being assessed in this survey, it was important to avoid conducting it at a time
that is either highly stressful (approaching final exams) or not stressful at all (beginning of semester when
workload is low) as outlined in methodology. The time chosen is a time that was perceived to be a neutral
medium between highly stressful and stress-free to avoid skewing the results toward either bias. The time
at which this stress is felt most was determined to be the period in which examinations are nearing. A study
has shown that “stress levels increased significantly throughout the semester”, and showed that stress was
experienced during the later weeks of the semester, indicating that examinations are a major cause of stress
in students and may manifest into certain habits such as the inability to eat (Pitt et al., 2018). The cause of
such stress was determined to be examinations, time management and employment.
Contrary to past research which has indicated that longer working hours such as those experienced by
fulltime employed students, have a detrimental effect on students’ feelings of anxiety, stress, and selfefficacy (Betzold, 2013; Elling & Elling, 2000; García-Vargas et al., 2016), the results obtained in this
study contradict this assumption. The most common stress rankings reported by male populations with and
without part-time jobs were 4 and 7 respectively. However, the most common stress ranking in the female
populations was 7, regardless of whether they had a part-time job. Therefore, it cannot be assumed that a
part-time job has an increasing negative impact on the level of stress experienced by college students (figure
1).
Other causes of stress during the college year were assessed via open-ended questions. Difficulties with
time management was identified as a major stressor by 37.2% of females and 20% of males. Workload and
deadlines were indicated by 17% of females and 32.5% as causes of stress. Therefore, the cause of stress in
students may be a combination of stressors rather than a single stressor.
Music has previously been reported to impact the psychobiological system positively (Thoma et al., 2013).
Thus, the findings that one of the most used mechanisms used to manage stress was listening to music was
not unexpected (figure 3, 57.9%). Researchers at Stanford University have said that “listening to music
seems to be able to change brain functioning to the same extent as medication” (Saarman, 2006).
Furthermore, research has shown that music with a strong beat stimulates the brain, causing brainwaves to
resonate in time with the rhythm. Slow beats encourage slow brainwaves, associated with hypnotic or
meditative states, while faster beats encourage more alert and concentrated thinking (Saarman, 2006).
Ozbay proposed that “Social support may moderate genetic and environmental vulnerabilities and confer
resilience to stress” (Ozbav, et al., 2007). Talking to others was determined to be another key coping
mechanism among the student population (figure 3). This may be due to the effect that talking to others has
on the bodily system in reducing stress. Social connections have been reported to be important in successful
stress management strategies (Apa.org, 2020). A study conducted at USC Marshall school of Business
determined that specific interaction with someone who genuinely understands your emotion and response
and is ideally experiencing it at the same time, will provide measurable relief from stress (Townsend, 2013).
It was noted that 37.8% of females and 30% of the males reported they “do not cope well with stress” when
reporting coping mechanisms in figure 3. The absence of an appropriate coping mechanism in this
population may contribute to further negative impacts of stress on the health of the individual. This finding
was reflected by most of the student respondents agreeing that stress has a negative impact on their mental
health. Almost 12,000 students sought counselling in the last academic year according to data compiled by
Psychological Counsellors in Higher Education Ireland (PCHEI). Anxiety accounted for half of all such
referrals last year, while there has been a sharp increase in the cases of self-harm (up from 5 to 11 per cent)
and identity issues (from 8 to 14 per cent) in recent years. Of the students taking part in the survey 42.5%
suggested that universities should “incorporate mental health information in lectures towards exam time”
and that faculty departments should “communicate” amongst each other. Other suggestions included
“stress management workshops should be held throughout the year”, “more tutorials” and “improve the
counselling service”.

CONCLUSION

It can be concluded from this study that university students experience an alarmingly high level of
daily stress, reflected by an average ranking of 7 of out 10 for both males and females. When
taking a part-time job into consideration, it was surprising that stress levels remained unchanged
and that this did not seem to be factor contributing to increased stress. The suggestion that people
do not react in the same manner when face with similar stressors was justified as a variety of
coping mechanisms were selected by the students, of which talking to others, music, technology,
and exercise prevailed in both males and females. In addition, it is universally agreed that elevated
levels of stress have a negative impact on student mental health. As there has been an absence of
Irish studies conducted to assess these parameters, the results of this study may provide a basis for
further research into stress tolerance among third level students and provide information to
colleges for implementation of resources that could help resolve these stress levels experienced by
students.
It is possible that subjective interpretation of the stress scale from 1-10 could be misunderstood. One student
may perceive a particular ranking to be highly stressful, whereas another student may perceive the same
ranking to be less stressful. If re-conducting this survey, an additional question could be included
determining the perception of the ranking scale. In addition, the survey could be carried out at different
times of the year to quantitatively determine the exact period that is most stressful in the college year rather
than the qualitative analysis that took place in this single survey.
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ABSTRACT
The aim of the current study was to establish the health, personal and social factors that influence the
use of vitamin/supplements (VS) among college students in Ireland. An online questionnaire was
carried out on 495 Irish third level students during March 2021. The questionnaire included enquiries
about demographic characteristics, understanding of health, VS use and factors that influence this. VS
use was reported by 82.6% of the surveyed population despite previously published reports that VS
usage is typically higher in older cohorts. It was seen that Vitamin D, multivitamins and iron are used
most commonly. This usage was highly influenced by the desire to maintain general health on a personal
level and also encouraged more socially by global health threats. Students' use of VS is affected by a
broad array of factors. The most common health related factor that influenced VS use was the emerging
correlation between Vitamin D and improved COVID-19 prognosis. Recommendations from friends,
family and word of mouth proved to be the most influential social factor while on a personal level
maintenance of general health was the most impactful factor. This highlights a worrying trend as it is
clear a gap exists between medically diagnosed deficiencies and VS usage. Existing knowledge could
be enhanced with additional information and education on this topic for both the consumer and medical
professionals.

KEYWORDS: Vitamins, supplements, college, students, Irish.

INTRODUCTION
A food supplement is defined by the European Food Safety Authority as a concentrated source of
nutrients or other substances with a nutritional or physiological effect, whose purpose is to supplement
a normal diet (EHSA, 2017). The use of vitamins/supplements (VS) has been seen to steadily increase
with time, perhaps owing to the increased variety of VS available which has increased from 700 in 2007
to 2,500 in 2017 (Food Safety Authority of Ireland, 2020). This is also due in part to the personal, social
and health related factors perceived by the user that change with time. Due to the rapid changes seen in
such trends, the findings of this study would be better complimented by more recent reports however
this data was not available at the time of analysis.
The global dietary supplement market size was estimated at $140.36 billion in 2020 and is expected to
reach $151.85 billion in 2021 (Grandview Research, 2018). This lucrative market requires regulation
to protect both product integrity and consumer safety. The EU Register of Nutrition and Health claims
provides a reference of the acceptable health claims that can be made by a product with the aim of
protecting the consumer from emphatic advertising and marketing efforts (EU Commission, 2008). This
ensures that any claim made in the EU is clear, accurate and based on scientific evidence.

The evidence from numerous studies shows that VS users differ from non-users in demographic
characteristics as well as certain psychological factors (Dickinson and MacKay, 2014). VS use in many
populations has been consistently reported to increase with age, education, and socioeconomic status,
with females being more likely to use VS also (Dickinson and MacKay, 2014). Previously reported
reasons for VS use refer to improvement and maintenance of general health and help in attaining
recommended intakes. These associations with VS use have been studied extensively in other countries,
however little is known about VS users and non-users in Ireland.
VS use in Ireland is most relevant in the context of Vitamin D supplementation. Vitamin D deficiency
is common across all age groups in Ireland with 47% of 18–39-year- olds suffering from this deficiency
(Joint Committee on Health, 2021). The recommended intake of 20-50ug per day cannot be met by diet
alone constituting the need for supplementation (Joint Committee on Health, 2021). This represents
warranted use of VS across the population, exemplifying a rich environment in which to study VS
consumption in a broader context. However, this is outside the scope of the current study.
The aim of the current study was to determine the health, personal and social factors that influence VS
use among Irish students, the first investigation of this kind in this population.

MATERIALS AND METHODS:
Survey Population
This study is based on Irish third level students between the ages of 18 to 30+, conducted from March
1st to March 29th, 2021. Three demographic characteristics were used as covariates in the analysis:
gender, age and perception of own health status to which the respondents belong. A total of 500 students
were surveyed of which 495 were deemed valid. Excluded were those who did not provide valid
acknowledgement of consent.
Ethical Approval
An ethics application was made to the module co-ordinators in lieu of MTU Research Ethics Committee
and submitted on the 23rd of February 2021. The application form provided details on the research
protocol through a series of yes or no questions and description of the research to be undertaken. In the
interest of ethics all data collected was anonymized. The participants were briefed on the purpose of the
study asked to consent to the collection and storage of the data provided. Data was stored on personal
computers with protective passwords. The data was retained for the duration of the research and
destroyed in June 2021.
Questionnaire Design
The survey was conducted using Google forms. The use of VS was ascertained using a combination of
open and closed question types with participants provided with the option for free text in some cases.
The analysis was limited to dietary supplements containing vitamins and/or minerals or both and
included those both freely available and medically prescribed. Individual and combined preparations of
vitamins and minerals were included. Excluded from this analysis were meal replacement products.
Mechanism of Distribution
Surveys were distributed online via University College Cork’s student survey database. Social media
were also used as a means of distribution via link sharing on Facebook and WhatsApp.

Mechanism of Data Analysis:
Data generated from the Google forms survey were transformed and gathered on Microsoft Excel for
analysis, being also categorical in nature. Likert scale analysis was applied to appropriate questions and
analysed accordingly in terms of percentage of total survey population. Options provided in free text
were also analysed and tabulated accordingly. Bar charts were used to represent the data provided in
relation to the main reasons, personal factors and health related influences that impact the student’s use
of VS.

RESULTS
Participant Characteristics
A total of 495 student responses were included in the analysis. The participants were characterised as
follows: Sex (77.2% females, 22.2% male, 0.4% non-binary, 0.2% prefer not to say.) The age of the
population ranged from 18 to 30+ with the age breakdown as follows: (18-20, 35.4%.) (21-23, 43.6%)
(24-26, 7.5%) (27-29, 3.8%.) (30+, 9.7%).
Participants were also characterised in terms of college department (29.3% Science, Engineering and
Food Science), (25.7% Medicine and Health), (21.8% Arts, Celtic Studies and Social Science), (18.8%
Business and Law), (4.4% Other).
Participants’ Health and Prevalence of Vitamin/Supplement usage
When asked to rate their health, participants responded as follows: 31.9% very good, 51.7% good,
13.9% moderate, 2.4% poor, 0% very poor.
Participants were then asked whether they use vitamins or supplements with 82.6% responding yes and
17.4% responding no. In addition to this, participants were asked which vitamins/supplements they use,
as summarised in table 1 in which % represents the percentage of respondents. Of the survey population
who take VS, 75.3% indicated that they take more than one vitamin/supplement while 24.7% take only
one.
The survey population who do not use vitamin supplements were asked to provide reasons for this
choice. A selection of common reasons were provided along with the option of free text with
participants invited to select as many options as applied to their choice. A total of 88 valid responses
were obtained of which 63.6% selected only one reason for their choice while the remaining 36.4%
selected 2+ reasons for choosing not to take VS. The results are summarised in table 2.

Table 1: Breakdown of vitamins/supplements used by 82.6% of survey population.
Vitamin/Supplement

%

N=

Vitamin D

19.3

240

Multivitamins

16.2

Iron

%

N=

Biotin

0.16

2

201

Iodine

0.16

2

13.7

170

Echinacea

0.16

2

11

137

Spirulina

0.16

2

Omega 3/Fish Oil

9.08

113

Coenzyme Q10

0.16

2

Vitamin B (incl. B12)

8.6

107

Curcumin

0.16

2

Magnesium

5.6

70

Antioxidants

0.08

1

Zinc

5.2

65

DIM

0.08

1

Calcium

3.1

39

Peppermint capsule

0.08

1

Probiotics

1.52

19

Glucomannan

0.08

1

Vitamin A

1.2

15

Glucosamine

0.08

1

Evening Primrose Oil

0.8

10

L-arginine

0.08

1

Folic Acid

0.56

7

Lysine

0.08

1

Protein Powder

0.32

4

Lemon Theanine

0.08

1

Collagen

0.24

3

Ginseng

0.08

1

Ashwaganda

0.24

3

Menomin

0.08

1

Revive active

0.24

3

Vegan Supplement

0.08

1

Creatine

0.16

2

Stress Reducing Supplement

0.08

1

Apple Cider vinegar supplement

0.16

2

Royal Jelly

0.08

1

Vitamin E

0.16

2

Rhodiola Rosea

0.08

1

Vitamin K

0.16

2

Ginkgo Biloba

0.08

1

Selenium

0.16

2

Hair, Skin, Nail supplement

0.08

1

Vitamin C

Vitamin/Supplement

Table 2: Analysis of the reasons why students did not use vitamins/supplements in a survey of Irish
students aged 18 years and over (N=86):
Reason

Percentage of Respondents (%)

I find it too difficult to get into the habit

30.4

I believe my diet satisfies my requirements

26.4

I do not feel confident in choosing a vitamin/supplement for myself

17.6

I do not believe the proclaimed benefits of vitamin/supplement usage

8.8

Cost

7.2

I did not see benefits from previous use

6.4

No evidence for vitamin/supplement usage in the absence of
deficiency

1.6

Never thought about taking a vitamin/supplement

0.8

Adverse reaction to vitamin usage (Vit C, Headaches)

0.8

Participants were also asked to describe the frequency of their VS usage. From students who provided
valid responses (n=418) results were as follows: Every day (66.74%), Regularly (2-3 times a week)
(22.72%), Seasonally (6.46%), In response to events (e.g. disease outbreaks/holidays abroad) (2.63%),
As remembered (0.96%), In response to deficiency testing (0.48%).
Of the total survey population (n=495), 37.2% had been tested for a vitamin or mineral deficiency while
the remaining 62.8% had not been. When asked to provide details of such testing a total of 182 valid
responses were obtained with results analysed in terms of individual vitamin/mineral deficiencies which
resulted as follows: B vitamins, including B12, (60.9%), Iron (35.3%), Vitamin D (22.2%), Broad panel
blood test for deficiencies (5.3%), Calcium (3%), Folic acid (2.6%), Vitamin C (1.9%), Zinc (1.1%),
Iodine (0.8%), Copper (0.4%), Potassium (0.4%), Phosphorus (0.4%), Magnesium (0.4%), Vitamin A
(0.4%).
Influences and Purposes for Vitamin/Supplement Usage:
The survey population that uses vitamins/supplements (n=412) were asked to further describe the
health, personal and social factors that influenced their VS use.
Participants were invited to select all reasons that applied to their VS usage, with the option for free text
provided. The main reasons for VS intake were as follows: Boosting immune system (28.3%),
deficiency prevention (25.5%), improving energy levels (24%), nutritional requirements (19.9%),
symptom relief (1%), cosmetic/beauty purposes (0.9%) and mental health improvement (0.3%). A total
of 20.6% of the survey population (n=412) did not detail the main reasons for VS usage.

Figure 1: The main reasons for vitamin/supplement intake.

A total of 40% of the survey population said that no health-related factors encouraged their VS use. The
remaining 60% were asked to select all reasons that applied to their intake with the additional option
for free text. Answers are in terms of multiple options. Taking vitamin D as a result of COVID-19
(47.5%) was the most common factor. A third of the survey population (34.1%) thought cold and flu
outbreaks to be an encouraging factor for the use of vitamin C. Magnesium was used by 9.5% of
respondents in response to poor sleep/stress. The most prevalent factor detailed in free text was iron to
prevent anaemic conditions (3.3%).

Figure 2: Health related factors that encouraged vitamin/supplement intake among the survey
population.

Respondents were provided with common influences of VS usage and provided with the option of free
to disclose any influences that apply. Analysis accounts for multiple options selected by respondents.
The influences for VS use were as follows: influenced by friends/family/word of mouth (40%), advised
by doctor/healthcare professional (29.8%), in response to a vitamin deficiency (17.2%), encouraged by
advertisements (4.9%), self- research (4.7%), learned about the importance in college modules (2%)
and in response to an illness (1.3%).

Figure 3: Personal and social factors that influenced use of vitamins/supplements.

Personal Understanding and Behaviour regarding Vitamin/Supplement Usage:
It was important to address how understanding of VS influenced behaviour and opinions. Therefore,
participants were asked whether they believed all VS preparations for any vitamin are created equally.
Results were as follows: Yes (11.5%), No (53.3%), I do not know (35.2%).
The survey population who believed all VS were not created equally were asked what they think makes
a particular VS superior. Respondents (n=298) were asked to choose from a selection of common
options and were also invited to disclose any extra information in the option for free text in which the
following results were obtained: dose per unit (23.3%), ingredient type (21.1%), third party verification
(21%), form (tablet, liquid, spray, gummy) (17.5%), cost (16.5%), bioavailability (0.4%), and brand
reputability (0.1%).
The participants’ understanding of the role of VS in health was explored by asking if they had little
disposable income whether they would choose to improve their health through food choices/nutrition
or through supplementing with VS. 88.1% said they would improve their health through food
choices/nutrition while the remaining 11.9% said they would choose to supplement with VS.

DISCUSSION
A survey was conducted of students in third level education in Ireland in 2021 with the aim to establish
health, personal and social factors that affected how the students incorporate vitamins/supplements (VS)
into their lifestyles. Food supplements are defined by the European Health Safety Authority as
concentrated sources of nutrients or other substances with a nutritional or physiological effect. (EHSA,
2017). It is believed that this is the first investigation of its kind among third level students in Ireland.
In order to perform a critical investigation of VS usage among an Irish student population, it was first
important to gain an understanding of how participants perceive their own health. Likert scale analysis
was applied, with the majority of participants rating their health as good (51.7%) or very good (31.9%).
Of the 495 valid responses obtained, 82.6% were VS users while the remaining 17.4% were not. The
incorporation of VS into one’s routine is influenced by a number of factors and therefore a comparison
was made between both those who use VS and those who choose not to.
Of 418 VS users, 66.7% consume VS daily, indicating that VS are a part of their everyday routine and
are seen as a positive contributor to health. VS are used seasonally by 6.5% of respondents suggesting
they are conscious of potential associated benefits, relating to, for example. cold and flu symptoms
during flu season, thus having a positive outlook on VS usage. A further 2.6% take VS in response to
events (e.g., disease outbreaks/holidays abroad) indicating that their intake is influenced by current
affairs such as the COVID-19 pandemic and emerging research that links Vitamin D to improved
prognosis due to its role in the orchestration of the innate and adaptive immune response (McCartney
and Byrne, 2020).This indicates that attitudes are malleable and students are open minded to new
emerging research that links to their wellbeing.
Notably, less than 1% (0.96%) of users revealed they only take VS as they remembered, indicating that
intake is not a habit they prioritise when considering their health. A final 0.5% of users do so in response
to deficiency testing. It is not clear whether this low percentage may be due to the lack of deficiency
testing amongst the student population or conversely, the absence of deficiency as a result of participants
being regular users of VS, preventing states of deficiency developing. A study of students across 5 U.S
universities revealed that college students consume more dietary supplements than the general
population (Liebermann et al. 2015). Moreover, it has been proven longitudinally that supplementation
increases with age, making it likely that habits formed during student life will not only continue but
develop further (Liebermann HR et al. 2015).

Of the VS users surveyed, the majority (54.9%) reported being satisfied that their chosen VS lived up
to its claim. A further 16.8% reported being very satisfied with their chosen VS while just 1.5% report
being unsatisfied with the VS used. A health claim is any statement that establishes a relationship
between dietary intake of a substance and health. The EU register of Nutrition and Health Claims
provides a library of both authorised and non-authorised health claims that can be made by an individual
nutritional supplement based on scientific research, prohibiting the sale of misleading products in the
EU (EU Commission 2008). The students’ awareness of this legislation was not established in the
current study nor was the basis of their satisfaction (medically defined or personal opinion).
Levels of satisfaction among the survey population cannot be attributed to the efficacy of the VS used
alone however, due to the myriad of personal factors that define satisfaction. It is difficult to define
what is meant by a satisfactory result from VS use when this usage is not prescribed in a medical context
and instead takes place outside medically quantifiable terms. Instead, this is more heavily reliant on
personal opinion and perception of health on an individual basis. The potency of the placebo effect
should be considered as the field of nutritional supplement research tends to neglect the use of placebo
in supplementation studies (Frame, 2018). Satisfaction may also be affected by how compliant the user
was relative to the products’ recommended guidelines, whether or not deficiency was present and thus
ameliorated by use or, whether the user had no insufficiencies due to a well-balanced diet and lifestyle
to begin with.
Of the population identified as users, 75.3% use more than one VS regularly while the remaining 24.7%
take only one. Evaluation of the individual VS used by students (Table 1) revealed that Vitamin D was
the most common choice (19.3%), followed by Multivitamins (16.2%) and Iron (13.7%). The
prevalence of Vitamin D usage among an Irish student population in 2021 can be contributed to both
long-standing awareness of Vitamin D insufficiency in Ireland (O’Sullivan et al. 2008). A report
published by House of the Oireachtas Joint Committee on Health revealed that 47% of 18–39-year-olds
in Ireland had a Vitamin D deficiency (Joint Committee on Health, 2021). The current pandemic climate
in which Vitamin D levels are positively correlated with improved prognosis regarding COVID-19
(McCartney & Byrne, 2020). This correlates further with motivations for usage detailed by students
with 47.5% of those taking Vitamin D doing so as a result of COVID-19 (Figure 2), which demonstrates
the impact of health-related factors on VS use.
Personal factors that influence VS use are also represented in the results generated. A large proportion
of students in Ireland take VS preventatively regarding future health problems, as seen in Figure 1.
Among the 418 users, 28.3% reported using VS to boost their immune system while 25.5% mentioned
that their VS use was in an effort to prevent or manage deficiencies. The use of VS to maintain health
was also identified as the most frequent motive in previous studies conducted, regardless of the age of
participants (Frey et al., 2017). A study carried out among German adults indicated ‘prevention of
nutrient deficiencies’ (62.4%) and ‘achievement or improvement of general well-being’ (34.7%) as the
most common motives for VS use (Frey et al., 2017).
Taking VS for additional personal benefits besides prevention was also reported in this study in Figure
1 such as for the improvement of energy levels (24%). The basis for taking VS to improve energy was
explored in a study among various populations worldwide, identifying that the decreased fatigue levels
noted by the participants after starting various supplements may have been due to pre-existing
deficiencies being managed (Tardy et al., 2020). Interestingly, 19.9% of students reported their use of
VS was due to personal nutritional requirements as vegans or vegetarians. The large proportion of this
group may be contributed to the age of the participants in this study with 54% of the vegan population
and 48% of the vegetarian population in Ireland being between the ages of 18-34 (Bord Bia Insight
Centre, 2018).
To gain a further insight into this role of VS in health, the student’s likelihood of improving their health
through food choices or through use of VS while having little disposable income was explored. A large
proportion (88.1%) admitted they would improve their health through their nutritional choices while
the remaining 11.9% said they would use VS as a means of improving health. The majority of students

choosing to use nutrition as a means of improving health could be due to the students broad
understanding that having a
varied and balanced diet is sufficient for providing the vitamins and minerals needed (Tardy et al.,
2020). Consequently, the 11.9% who would choose VS could be made up of those who are unable to
get the required nutrients through their diet and require extra VS, such as vegans, vegetarians, and those
with vitamin deficiencies. This highlights how complex VS use is in the absence of definitive deficiency
testing.
Based on a study by Frey et al., (2017), common reasons related to general health are often reported to
justify the use of VS. However, other studies have suggested that many VS users perceive supplements
to be healthy but were unsure of what exact benefits or risks were associated with VS use (Barnes et
al., 2016). This is reflected in the non-users surveyed in the current study of which 17.6% admitted they
do not feel confident in choosing a VS for themselves. This presents an opportunity for deficiency
testing to provide confidence to the VS user regarding their choice of VS and also the need for this.
The current study expanded on this literature to find that when asked directly about health-related
factors that may have encouraged or influenced VS use, various reasons were provided for specific VS
use, as seen in Figure 2. The results demonstrate an interesting trend, with a total of 47.5% of VS users
reporting that the current understanding of Vitamin D enhancing the immunoprotection against SARSCoV-2 encouraged them to supplement with Vitamin D (McCartney & Byrne, 2020). Similarly, it was
discovered that 34.1% of students were encouraged to take Vitamin C in response to cold or flu
outbreaks while 9.5% admitted to taking magnesium supplements because of poor sleep or periods of
stress. These results from Figure 2 agree with the aforementioned statement that students are adaptable
to incorporating new VS into their diets in response to external cues such as emerging research
associated with health but are also aware of responses in their own bodies associated with a need for
supplementation.
A study carried out on an Australian student population discovered that >50% of participants were
uncertain of the effectiveness of the VS they used (Barnes et al., 2016). It is likely that this is due to
difficulty in acquiring sources of information regarding which VS to use. When questioned on whether
the students were aware if all VS were equal in their quality or concentration, 35.2% stated that they
did not know, highlighting the requirement for further education on VS.
The current study also investigates the social factors that influenced the use of VS in the student
population, as summarised in Figure 3. Interestingly, 40% of the population revealed they would be
influenced to use VS based upon friends, family, and word of mouth. I
Conversely, 29.8% of students indicated their VS use was based upon advice from a doctor or healthcare
professional. While this appeared to be a more trustworthy health source, a study carried out on medical
students in Serbia suggested that the education in university modules on VS was lacking and that these
healthcare professionals would not feel confident in identifying a VS for a patient to use (StanojevićRistić et al., 2017).
Of non-users of VS surveyed, 30.4% attributed their non-use to difficulty faced in adopting the habit of
taking VS regularly (Table 2). Habit formation is central to a healthy lifestyle and research has shown
that VS users are more likely to adopt habits conducive to health such as a consciously balanced diet
and regular exercise habits than non-users (Dickinson et al. 2014). The intrinsic motives of users may
explain their decisions to incorporate VS in active pursuit of optimal health and well-being despite this
attitude and behaviour profile affiliating them with the population who require supplementation least
(Dickinson et al. 2014). This is an example of habit aggregation that is seen among students and indeed
the general population that increases positively with age and year of study in the context of health as
described by a study of students in Queen’s University Belfast and University of Ulster, Northern
Ireland (Gray, 2006).

It appears that there is somewhat of an understanding of this concept among the student population as
26.4% of VS non-users said that a satisfactory diet justified their decision not to supplement. In the
absence of clinical deficiency, VS usage does not reduce the risk of developing non-communicable
disease such as cardiovascular disease, cancer and type 2 diabetes mellitus according to results obtained
in randomised controlled trials (Zhang et al., 2020). A balanced diet lowers the risk of developing such
disease states when sustained across the lifespan (CDC 2021).
The aim of the current study was to establish the health, personal and social factors that determine the
use of VS among Irish third level students. It was discovered that students actively engage in VS use.
Of the student population surveyed (n=495), 82.6% identify as VS users. When this is contrasted with
the proportion of the same population who have been tested for deficiency, (37.2%) it is apparent that
there is a gap between levels of usage and levels of testing. VS use among college students is found to
be more influenced by nonmedical advice, particularly from friends, family or word of mouth in 40%
of cases. This identifies the impact of social influence when choosing to improve one’s health, raising
the question of whether the general population, as represented by students in this case, have greater
confidence in non-medical, media type information sources than traditional medical advice. As
established by Stanojević-Ristić et al, (2017), healthcare professionals felt their knowledge of VS from
university degree level was insufficient when advising patients. From this it becomes apparent that VS
knowledge and information needs to be disseminated from expert level not only to the consumer
directly, but also to medical professionals.
Aside from mainstream marketing of VS, additional education or information on such products would
be well received by the student population having determined the baseline level of interest in this study.
The significance of VS use in student life could be better explored across an extended time period
spanning multiple seasons with change in tendencies noted. The current COVID-19 pandemic has
induced hyperawareness of health and wellbeing with a potential increase in VS usage as a result. This
represents the impact of health-related factors on VS usage among students. This cannot be disclosed
with certainty as this study provides the first detailed investigation into this topic among the student
population in Ireland, however.
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ABSTRACT
Objectives: To explore the consumption of caffeine containing beverages by the Irish population and
to investigate their self-perceived dependency on such products.
Methodology: An online survey was distributed with national access to Irish adults which was open to
responses from 25th February to 7th March 2021 inclusive. A total of 417 responses from participants
over 18 years of age was validated and analysed using Microsoft Excel.
Results: Tea was the most commonly consumed caffeinated product among the Irish population, with
the majority of respondents stating their consumption began before 10 years old. The majority of
respondents did not believe themselves to be dependent on caffeine; however their self-reported intake
could imply otherwise. Reports of withdrawal symptoms and evidence showing a lack of awareness
regarding the presence of caffeine in certain regularly consumed beverages were noted.
Conclusion & Recommendations: Caffeine is widely consumed throughout the Irish population. An
association between self-reported dependency and higher caffeine intake per day was noted. The Irish
population could be made more aware of caffeine content in products, which can be achieved through
improved labelling of such goods. Result of this study suggest the potential benefit of educating the
public on caffeine dependence syndrome and the risks associated with high levels of caffeine
consumption. Introducing a legal age for purchasing highly caffeinated products could be considered.
The lack of standardised unit measurements and the bias of self-reported data presented limitations in
this study.

INTRODUCTION
Caffeine is a widely consumed psychoactive drug whose popularity has significantly increased in recent
years due to its ability to stimulate and energise consumers, while also promoting enhanced mood and
alertness (Dias et al., 2015; Heckman et al., 2010). The most common sources of caffeine in beverages
include coffee, black tea (caffeinated), energy drinks (e.g. Red Bull®, Monster Energy®) and CocaCola® (Mitchell et al., 2014).
In a paper published by Heckman et al. (2010), it is stated that in an average 8oz (240ml) cup, caffeine
content is as follows: instant coffee – 93mg, black tea – 47mg, Coca-Cola® – 23mg, energy drinks –
76-80mg. Both hot chocolate and decaf tea/coffee contain 3.2mg of caffeine per 8oz (Nicholson, 2008).
It must be emphasised that caffeine content can vary considerably between cups of tea or coffee due to
factors such as brewing time, different strengths and brands (Heckman et al., 2010). While coffee has
been found to be the major source of caffeine in Europe and the United States, tea is the most frequently
consumed caffeinated beverage in Ireland (Verster & Koenig, 2018).

Caffeine dependence syndrome is recognised by the World Health Organisation, who utilise the
International Statistical Classification of Diseases and Related Health Problems (10th Revision) (ICD10) for diagnosis (Meredith et al., 2013). ICD-10 lists 9 criteria for the diagnosis of the disorder, which
are the same diagnostic criteria used for mental and behavioural disorders caused by usage of drugs
including alcohol, opioids, cocaine and tobacco (WHO, 2016).
The signs and symptoms of caffeine dependence syndrome, i.e. withdrawal symptoms, generally
become apparent within 24 hours of cessation or reduction of caffeine intake (APA, 2013). These
symptoms include headache, fatigue, drowsiness, depressed mood, irritability, difficulty concentrating,
and flu-like symptoms such as nausea, vomiting and muscle pain.
The purpose of the current study was to assess the role of caffeine in Ireland, the attitude of the Irish
population towards caffeinated beverages, and the dependency of this population on such products.

METHODOLOGY
Survey Population
A questionnaire was drawn up consisting of a series of questions distributed to the students of University
College Cork, along with various businesses and organisations. Individuals aged 18 and over and
resident in the Republic of Ireland were asked to participate in this anonymous survey. Ethical approval
was granted by module coordinators on behalf of MTU following submission of an application for
ethical approval using the MTU ethics application form.
Survey Questions
An online survey was created using Google Forms which comprised 25 questions consisting of both
open and closed ended formats. To avoid bias, an equal number of options was put either side of a
neutral response in any questions where a level of agreement or disagreement was required.
Distribution
The survey was disseminated via social media, primarily Facebook and WhatsApp, and email. The
survey was open to responses from 25th February to 7th March 2021 inclusive.
Data Analysis
The data collected from this survey were analysed using Microsoft Excel and interpreted through the
creation of pivot tables and subsequently pie charts, bar charts and tables. Separate spreadsheets were
created for each research question and answers were analysed both independently and in conjunction
with other relevant data obtained.

RESULTS
Responses And Demographics
A total of 423 responses was recorded from the Google Forms survey. Respondents who do not
consume any form of caffeine (six respondents) were excluded. Therefore, this survey produced 417
valid responses which could be analysed, whose demographics are shown in Table 1. Due to technical
issues encountered on some mobile devices for question 9 (analysed in Figure 2), a

further 120 responses had to be discounted for analysis of this question only, leaving 297 valid responses
to be analysed for this question alone.

Table 1: Survey Population Demographics.
Gender

% & number of respondents
Female

74% (n=307)

Male

26% (n=110)

Age group

% & number of respondents
18-20

12% (n=51)

21-25

18% (n=74)

26-35

13% (n=54)

36-45

13% (n=54)

46-55

26% (n=109)

56+

18% (n=75)

Occupation

% & number of respondents
Employed
Educator

16% (n=68)

Administrator

16% (n=66)

Healthcare

7% (n=28)

Other

24% (n=101)

Student
Second level

6% (n=23)

Third level

20% (n=82)

Retired

6% (n=26)

Other

5% (n=23)

Consumption
Most Regularly Consumed Caffeinated Product
Participants were asked which caffeine containing product they consumed most regularly, with
responses presented in Figure 1. A total of 45% (n=186) consumed tea most regularly, with 42%
(n=174) stating that they consume coffee most often.

6%
Coca-Cola®
Coffee
45%

Decaf drinks
42%

Energy drinks
Hot Chocolate
Tea

3%

1%

3%

Figure 1: Determination of the Most Commonly Consumed Caffeine Containing Products in the Irish
Population.

Reasons For Participants’ Consumption Of Caffeine Products
Table 2 displays all relevant reasons why respondents consume caffeine, chosen from a series of
predetermined options. Taste was the most common reason for caffeine intake across the majority of
the caffeine products in question. Other reasons stated by participants as to why they consume caffeine
included for enjoyment and warmth.
Table 2: Reasons for Participants’ Consumption of Caffeine Products.
Reason for consuming caffeine

% & number of respondents

For taste

64% (n=268)

Out of habit

51% (n=211)

For social reasons

44% (n=185)

To combat tiredness/fatigue

34% (n=141)

To relax

33% (n=136)

To increase productivity

17% (n=72)

Other

2% (n=10)

Respective Age At Which Participants Began Consuming Individual Caffeinated Products
Figure 2 shows the age range at which participants began consuming individual caffeine products. Of
those who consumed tea, 47% (n=140) began at less than 10 years. The same trend can be seen for hot
chocolate (59%; n=175) and Coca-Cola® (48%; n=142). Of those who consumed coffee, 37% (n=109)
began when they were between the ages of 16-20 years. With regards to energy drinks, 19% (n=55)
began consumption when they were 16-20 years. *It should be noted that analysis of this question was
based on a total of 297 valid responses due to a technological error.

70%

Percent of Population

60%
50%
40%

Tea
Hot Chocolate

30%

Coca-Cola®
Coffee

20%

Energy drinks
10%
0%
<10 years

11-15
years

16-20
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21-25
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26-30
years

31-40
years

>41 years

Age Range

Figure 2: Age at Which Participants Began Consuming Caffeine Containing Products Among an Irish
Population.

Amount (Units) of Each Caffeine Product Consumed by the Irish Population
Participants were asked how many units (cups/cans) of caffeinated products they consume per day. As
shown in Figure 3, the majority (45%; n=188) of respondents stated they consume 2-3 units per day,
with 30% (n=125) consuming 4-5 units per day. A total of 17% (n=71) consume 0-1 units a day, with
8% (n=33) having more than six units daily. The majority of those who consume 6+ units of caffeine
daily are tea drinkers.
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Figure 3: Units of Caffeine Containing Products Consumed Based on Product.

Tea

Addiction And Dependency
Immediate Effect Of Caffeine Consumption On Participants
Participants were asked, out of a series of options, to select how they felt immediately after consuming
caffeine. One hundred and twenty eight participants (31%) experienced an uplift in mood and 27%
(n=111) felt more relaxed, whilst 22% (n=91) felt more energised immediately after caffeine
consumption. In terms of the negative effects of caffeine, 4% (n=17) felt ‘jittery’ after consuming
caffeine, whilst 2% (n=8) experienced heightened anxiety. A total of 47% of participants (n=198)
observed no change immediately after caffeine consumption.
Self-Recognised Dependency Of Participants On Caffeine Based On Most Regularly Consumed
Caffeine Product
Figure 4 highlights participants’ perception of their dependency on caffeine products on a scale of 1 to
5 – one being not dependent at all, and five being very dependent. When analysing all caffeine products,
34% (n=143) said that they were not dependent at all, 24% (n=99) self-reported being a 2 on the scale,
22% (n=91) were a 3, 14% (n=57) were a 4 and 6% (n=24) said that they were a 5 – very dependent on
caffeine products. This trend was observed across the different products, except for coffee and energy
drinks. The largest group of coffee drinkers (27%, n=46) said that they were a 3 (neither dependent nor
not dependent).
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Figure 4: Participants’ Degree of Dependency on Caffeine Based on Most Regularly Consumed Caffeine
Product.

Degree Of Respondents’ Dependency Based On Amount Of Consumption
The participants’ self-reported dependency was compared to the average units they consume, as shown
in Table 3.

Table 3: Degree of Dependency Based on Consumption.

Degree of Dependency

All
Respondents

Average Units Consumed (Cups/Cans)
0-1 (n=70)

2-3 (n=188)

4-5 (n=123)

6+ (n=35)

1 - Not Dependent at all

34% (n=142)

78% (n=54)

35% (n=65)

14% (n=17)

17% (n=6)

2- Not dependent

24% (n=100)

11% (n=8)

29% (n=54)

27% (n=33)

14% (n=5)

3 - Neither dependent nor
not dependent

22% (n=92)

11% (n=8)

19% (n=36)

32% (n=39)

26% (n=9)

4 - Dependent

14% (n=58)

0% (n=0)

13% (n=25)

20% (n=25)

23% (n=8)

5 - Very dependent

6% (n=25)

0% (n=0)

4% (n=8)

7% (n=9)

20% (n=7)

Reduction Of Caffeine Intake And Respective Effects On Participants
Participants were asked if they had ever tried to reduce their caffeine intake and to describe any effects
they experienced. A total of 36% of the 417 participants (n=149) attempted to reduce their caffeine
intake. Reasons for this included the cost, for health reasons, and to improve sleep quality. Of these
149 participants, 17% (n=26) suffered headaches upon reducing their caffeine intake, 7% (n=11)
experienced reduced energy levels, and 9% (n=14) had improved sleep. In addition, 26% (n=38)
experienced no change when reducing their caffeine intake whilst 15% (n=23) stated that their caffeine
intake did not remain reduced. Two participants reduced their caffeine intake for health reasons and
found that their recurrent heart palpitations ceased, whilst another found that their flu-like symptoms
had reduced.

Public Perception
Participants’ Awareness Of Caffeine Containing Products
Participants were asked to state whether or not they thought particular products contained caffeine.
Every product listed contained caffeine. Analysis of 417 participants found that 65% (n=273) were
unaware of the presence of caffeine in hot chocolate, whilst 75% (n=314) were unaware of its presence
in decaf coffee/tea. A total of 7% (n=29) were unaware of the presence of caffeine in Coca-Cola®.
Over 95% of participants were aware of the presence of caffeine in coffee, tea, and energy drinks.
Before this question, 4% (n=16) of respondents claimed they did not consume caffeine. When informed
that all of the products listed contained caffeine, all 16 participants then stated that they do, in fact,
consume a caffeinated product of some form.
Perceived Social Acceptance Of Caffeine Dependency
When asked if participants thought caffeine dependency was socially acceptable, 68% (n=283) of
respondents believed it was, while 8% (n=35) did not and 24% (n=99) were unsure.

DISCUSSION
This study was carried out with the intention of understanding the role of caffeine in Irish society and
evaluating the caffeine products most commonly consumed by the Irish population. Survey
demographics highlighted a well distributed age range which was predominately female.
The current study found that the primary caffeinated beverages consumed among the surveyed
population were tea (45%) and coffee (42%) respectively (Fig. 1). These results were in line with a
recent literature review stating that tea is the principal source of caffeine in Ireland (Verster & Koenig,
2018). Hot chocolate, energy drinks and Coca-Cola® were found to be lesser sources of caffeine among
the Irish population in the current study, thereby supporting this review.
The results of the current study were in stark contrast with an American study carried out by
Drewnowski & Rehm (2016), who noted coffee as the most commonly consumed caffeine product at
64% of the total respondents, followed by tea at 18%. As the current study focused on Irish residents,
a discrepancy based on cultural standards must be taken into account. Residents of the Republic of
Ireland have been found to drink the most tea per capita in the world, 6 times higher than the global
average (Waugh et al., 2016).
Survey respondents were provided a list of possible reasons for their consumption of caffeinated
beverages and asked to choose all of which were true for them (Table 2). The most commonly answered
reason was due to the taste, which was selected by 64% of participants, and was consistent with a
number of previous studies (Turton et al., 2016; Bunting et al., 2013). In total, 34% believed caffeine
consumption helped to combat fatigue, an effect which has been previously documented (Heckman et
al., 2010). Of this 34%, 56% were primarily coffee drinkers. In contrast, tea was consumed most
regularly by those who drink caffeine to relax.
A total of 17% of respondents consume caffeine to increase productivity. Caffeine has been associated
with improved alertness, awareness and concentration, all of which result in increased productivity
(Mitchell et al., 2014; Heckman et al., 2010). One individual noted caffeine as a means of weight loss.
This is possibly due to an increased resting metabolic rate following consumption of caffeine (Higdon
& Frei, 2006).
Participants were also asked the ages at which they began consuming each of the stated caffeine
products (Fig. 2). The majority of individuals began drinking tea, hot chocolate and Coca-Cola® under
the age of 10 years. This is similar to a 2014 study conducted by Branum et al. in the United States
where fizzy drinks and tea were found to be commonly consumed in children and adolescent age groups.
In the current study, 41% of participants stated that their preferred caffeine product had changed over
time. The majority of these participants drank tea as a child and switched to coffee in their teenage
years, mainly between 16 and 20 years. Coffee was the most widely consumed amongst the 18-20 and
36-45 age groups. Tea was the most regularly consumed amongst the other age groups, with the
exception of those aged 46-55, where tea and coffee were equally consumed.
In addition, this study investigated the effects that participants experienced immediately after
consuming caffeine. The most prevalent effect experienced was an uplift in mood which was common
across each caffeine product. However, to continually experience this ‘uplift’ would require
participants to consume more caffeine, as depicted in a previous study which stated that repeated
caffeine intake eventually causes serotonergic neurons to undergo adaptive changes, reducing the
conversion of tryptophan to 5-hydroxytryptamine, potentially triggering depression in conditions of
caffeine withdrawal (Haleem et al., 1995). A trend found in the current study was that participants who
felt more energised or ‘jittery’ after caffeine consumption tended to consume coffee and energy drinks,
whereas those who felt more relaxed or experienced no change after caffeine consumption tended to
consume tea. While the difference in these effects is likely due to the larger caffeine content in
coffee/energy drinks compared to tea (Heckman et al., 2010), a study conducted by Quinlan et al. (2000)
noted the immediate effect of caffeine ingestion may be due to a conditioned response. This suggests

that the effects experienced by participants in the current study could be due to the outcome desired by
that individual (coffee/energy drink needed before an exam, or tea ingested late in the evening before
bed) rather than the direct effect of the caffeine.
According to WHO (2016), the nine criteria set out by ICD-10 for the diagnosis of caffeine dependence
syndrome are acute intoxication, harmful use, dependence syndrome, withdrawal state, withdrawal state
with delirium, psychotic disorder, amnesic syndrome, residual and late-onset psychotic disorder, other
mental and behavioural disorders and unspecified mental and behavioural disorders. The American
Psychiatric Association (APA) included caffeine dependence syndrome in the Diagnostic and Statistical
Manual of Mental Disorders (5th Edition) (DSM-5) as a condition for further study. DSM-5 proposed
a number of criteria for diagnosis of caffeine dependence syndrome including “a persistent desire or
unsuccessful efforts to cut down or control caffeine use… continued caffeine use despite knowledge of
having a persistent or recurrent physical or psychological problem that is likely to have been caused or
exacerbated by caffeine” and “withdrawal, as manifested by either of the following: (a) the
characteristic withdrawal syndrome for caffeine, (b) caffeine (or a closely related) substance is taken to
relieve or avoid withdrawal symptoms” (APA, 2013, p.792-793).
Considering this, the current study asked participants to rate their own perceived dependence on caffeine
containing products on a scale of 1 to 5 – one being not dependent at all, and five being very dependent.
The results of this were interpreted with regard to the most commonly consumed product (Fig. 4) and
with regard to the units of consumption (Table 3). It was found that the more units consumed by an
individual per day, the more likely they were to identify as dependent or very dependent. This is in line
with a recent study which stated that the severity of withdrawal symptoms has been found to increase
as the daily dose increases (Sajadi-Ernazarova et al., 2020).
The current study determined that those who consumed coffee most regularly were more likely than tea
drinkers to identify as dependent or very dependent, due to the fact that coffee contains one psychoactive
substance, caffeine, while tea contains four known psychoactive substances – caffeine, L-theanine,
theobromine and theophylline (Li et al., 2020; Nobre et al., 2008). These four substances work together
to produce a stimulated response, known as alert relaxation (Nobre et al., 2008). This ‘response’ from
caffeine alone, as in coffee, is a more wired feeling, which consumers associate more with consumption
of caffeine products (Haskell et al., 2007). This may account for the differences in self-perceived
dependency between tea and coffee consumption found in this study.
Participants were asked what symptoms they experienced when trying to reduce their caffeine intake.
The most prevalent symptom was a headache, followed by reduced energy levels. Some participants
experienced flu-like symptoms. These symptoms were in line with another study conducted on caffeine
withdrawal syndrome where the seven prevalent factors were noted as fatigue, low alertness, mood
disturbances, low sociability, nausea, flu-like feelings, and headache (Juliano et al., 2012). An
interesting note in the current study was that two participants’ recurrent heart palpitations ceased when
their caffeine intake was reduced. The underlying cause of these arrhythmias may be the elevated
homocysteine levels upon caffeine consumption (Katan & Schouten, 2005).
Furthermore, this study tested participants’ knowledge on the presence of caffeine in a variety of
beverages to assess the public awareness of caffeine containing products. The majority of participants
failed to recognise the presence of caffeine in hot chocolate and decaf coffee/tea. Another notable trend
was the lack of awareness of caffeine in Coca-Cola®. This finding takes precedence when considering
caffeine consumption amongst children, unbeknownst to themselves or their parents. In a previous
study of Caffeinated Sugar Sweetened Beverages (CSSBs) consumption in Icelandic children
conducted by Kristjansson et al. (2014), it was found that 19% of boys and 8% of girls aged 10-12 years
consume cola drinks daily. Whilst the public awareness of caffeine in energy drinks is well known, as
established by the current study, Kristjansson et al. found that 7% of boys and 3% of girls aged 10-12
consume energy drinks daily. CSSB use was associated with headaches, stomach aches, sleeping
problems, and low appetite in these children with a higher incidence after energy drink consumption
compared to cola drink consumption (Kristjansson et al., 2014). This lack of public awareness of

caffeinated products may lead to children consuming a larger amount of caffeine than otherwise
expected.
In addition to the aforementioned physical complaints that may arise in children, another concern is that
these caffeine drinks could put obese children at further risk of cardiac dysrhythmias and intracardiac
conduction abnormalities (Seifert et al., 2011). The elevated risk of hypertension from increased
caffeine consumption in children could exacerbate cardiac conditions such as hypertrophic
cardiomyopathy (Seifert et al., 2011).
Finally, survey participants were asked if they thought a caffeine addiction was socially accepted, of
which 68% believed it was. One recent study found that coffee and tea are the most consumed and
socially accepted stimulants in the world with 90% of adults consuming caffeine daily (Bordeaux &
Lieberman, 2020). When examining individual opinions on the topic, many stated that such an
addiction is not as harmful or stigmatised as other addictions, e.g. alcohol or drug addiction.
Many people view caffeine as a “fashionable” way of socialising when meeting friends for a coffee or
inviting someone over for tea. As a society, consuming caffeine is almost expected and people are often
surprised if somebody does not drink caffeine in any form. However, this also depends on the caffeine
type, as energy drink consumption is not as widely accepted. Many believe an age limit should be put
in place to limit purchases of highly caffeinated products such as energy drinks to prevent excessive
caffeine consumption by children, as was recommended by Gibson-Moore & Valentine (2007) in their
study which sought to limit energy drink consumption in American schools.
In conclusion, caffeine is widely consumed throughout the Irish population in various forms and, as
demonstrated in this study, self-reported dependency was associated with higher caffeine intake per
day. It is clear that a greater knowledge of the addictive nature of caffeine needs to be provided to the
Irish population. Additionally, caffeine content and information on caffeine dependence syndrome
should be made clear to the population, in the form of campaigns and better labelling of caffeine
products.
The possibility of increasing the legal age needed to purchase highly caffeinated products such as energy
drinks should be examined, considering the adverse effects that caffeine can have on developing
children and adolescents.
Study limitations included the omission of standardised unit measurements, which made evaluation and
comparison of participants’ caffeine consumption difficult. Self-reported data are subject to bias which
may also have occurred in this study.
Further studies which could be carried out in this field include an investigation into the long term effects
of consuming caffeinated products, as well as social pressure surrounding caffeine consumption.

ACKNOWLEDGEMENTS
We would like to thank Dr. Annmarie Burns (lecturer, MTU) and Dr. Brigid Lucey (Head of
Department of Biological Science, MTU) for their constant support and guidance throughout the
process of completing this paper. We would also like to thank Frances O’Sullivan (BSc (Hons)
Children’s and General Integrated Nursing) who provided unending guidance and editing of this paper.
All authors contributed equally to this work.

Corresponding author: Gavin Buckley (gavtombuckley@gmail.com)

REFERENCES
American Psychiatric Association (2013) Diagnostic and Statistical Manual of Mental Disorders, 5th ed.
American Psychiatric Association, Washington.
Bordeaux, B. & Lieberman, H.R. (2020) Benefits and Risks of Caffeine and Caffeinated Beverages. Wolters
Kluwer, Netherlands. Retrieved from https://www.uptodate.com/contents/benefits-and-risks-of-caffeine-andcaffeinated-beverages on 26/04/2021.
Branum, A.M., Rossen, L.M. & Schoendorf, K.C. (2014) Trends in Caffeine Intake Among US Children and
Adolescents. American Academy of Pediatrics, 133(3) p.386-393.
Bunting, H., Baggett, A. & Grigor, J. (2013) Adolescent and Young Adult Perceptions of Caffeinated Energy
Drinks: a Qualitative Approach. Appetite, 65, p.132-138.
Dias, T.R., Alves, M.G., Bernardino, R.L., Martins, A.D., Moreira, A.C., Silva, J., Barros, A., Sousa, M., Silva,
B.M. & Oliveira, P.F. (2015) Dose-dependent Effects of Caffeine in Human Sertoli Cells Metabolism and
Oxidative Profile: Relevance for Male Fertility. Toxicology, 328, p.12-20.
Drewnowski, A. & Rehm, C.D. (2016) Sources of Caffeine in Diets of US Children and Adults: Trends by
Beverage Type and Purchase Location, Nutrients, 8(3), p.154-154.
Gibson-Moore, H. & Valentine, S. (2009) Nutrition Standards for Foods in Schools: Leading the Way Toward
Healthier Youth. European Journal of Clinical Nutrition, 63(11), p.1375-1376.
Haleem, D.J., Yasmeen, A., Haleem, M.A. & Zafar, A. (1995) 24h Withdrawal Following Repeated
Administration of Caffeine Attenuates Brain Serotonin but not Tryptophan in Rat Brain: Implications for
Caffeine-induced Depression. Life Sciences, 57(19), p.PL285-292.
Haskell C.F., Kennedy D.O., Milne A.L., Wesnes K A. and Scholey A.B. (2007) The Effects of L-theanine,
Caffeine and their Combination on Cognition and Mood. Biological Psychology, 77(2), p.113-122.
Heckman, M.A., Weil, J. & De Mejia, E.G. (2010) Caffeine (1, 3, 7‐trimethylxanthine) in Foods: A
Comprehensive Review on Consumption, Functionality, Safety, and Regulatory Matters. Journal of Food Science,
75(3), p.R77-R87.
Higdon, J.V. & Frei, B. (2006) Coffee and Health: A Review of Recent Human Research. Critical Reviews in
Food Science and Nutrition, 46(2), p.101-123.
Juliano, L.M., Huntley, E.D., Harrell, P.T. & Westerman, A.T. (2012) Development of the Caffeine Withdrawal
Symptom Questionnaire: Caffeine Withdrawal Symptoms Cluster into 7 Factors. Drug and Alcohol
Dependence, 124(3), pp.229-234.
Katan, M.B. & Schouten, E. (2005) Caffeine and arrhythmia. The American Journal of Clinical Nutrition, 81(3),
p.539-540.
Kristjansson, A.L., Sigfusdottir, I.D., Mann, M.J. & James, J.E. (2014) Caffeinated Sugar-sweetened Beverages
and Common Physical Complaints in Icelandic Children aged 10–12 Years. Preventive Medicine, 58, p.40-44.
Li, J., Ma, J., Zhang, Y. & Zheng, L. (2020) Determination of 4 Psychoactive Substances in Tea Using Ultra High
Performance Liquid Chromatography Combined with the Quadrupole Time-of-flight Mass
Spectrometry. Analytical Methods, 12(40), p.4878-4884.
Meredith S.E., Juliano, L.M., Hughes, J.R. & Griffiths, R.R. (2013) Caffeine Use Disorder: A Comprehensive
Review and Research Agenda. Journal of Caffeine Research, 3(3) p.114-130.
Mitchell, D.C., Knight, C.A., Hockenberry, J., Teplansky, R. & Hartman, T.J. (2014) Beverage Caffeine Intakes
in the U.S. Food and Chemical Toxicology, 63, p.136-142.

Nicholson, P. (2008) Caffeine Consumption Linked to Miscarriage. Medical Post, 44(7), p.21.
Nobre A.C., Rao, A. & Owen G.N. (2008) L-Theanine, a Natural Constituent in Tea, and Its Effect on Mental
State. Asia Pacific Journal of Clinical Nutrition, 17(1) p.167-168.
Quinlan, P.T., Lane, J., Moore, K.L., Aspen, J., Roycroft, J.A. & O'Brien, D.C. (2000) The Acute Physiological
and Mood Effects of Tea and Coffee: The Role of Caffeine Level. Pharmacology, Biochemistry and
Behavior, 66(1), p.19-28.
Sajadi-Ernazarova, K.R., Anderson, J., Dhakal, A. & Hamilton, R.J. (2020) Caffeine Withdrawal. StatPearls
Publishing, Florida.
Seifert, S.M., Schaechter, J.L., Hershorin, E.R. & Lipshultz, S.E. (2011) Health Effects of Energy Drinks on
Children, Adolescents, and Young Adults. Pediatrics, 127(3), p.511–528.
Turton, P., Piché, L. & Battram, D.S. (2016) Adolescent Attitudes and Beliefs Regarding Caffeine and the
Consumption of Caffeinated Beverages. Journal of Nutrition Education and Behavior, 48(3), p.181-189.
Verster, J.C. & Koenig, J. (2018) Caffeine Intake and Its Sources: A Review of National Representative Studies.
Critical Reviews in Food Science and Nutrition, 58(8), p.1250-1259.
Waugh, D.T., Potter, W., Limeback, H. & Godfrey, M. (2016) Risk Assessment of Fluoride Intake from Tea in
the Republic of Ireland and its Implications for Public Health and Water Fluoridation, International Journal of
Environmental Research and Public Health, 13(3), p.259.
World Health Organization (2016) International Statistical Classification of Diseases and Related Health
Problems, 10th revision, 5th ed. World Health Organization, Geneva.

THE INTERNATIONAL

UNDERGRADUATE JOURNAL OF

Health Sciences
Dec 2021

THE INTERNATIONAL

UNDERGRADUATE JOURNAL OF

Health Sciences
VOL 1 | ISSUE 1

June 2021

